Selective etch for silicon films

Information

  • Patent Grant
  • 9754800
  • Patent Number
    9,754,800
  • Date Filed
    Monday, April 25, 2016
    8 years ago
  • Date Issued
    Tuesday, September 5, 2017
    6 years ago
Abstract
A method of etching patterned heterogeneous silicon-containing structures is described and includes a remote plasma etch with inverted selectivity compared to existing remote plasma etches. The methods may be used to conformally trim polysilicon while removing little or no silicon oxide. More generally, silicon-containing films containing less oxygen are removed more rapidly than silicon-containing films which contain more oxygen. Other exemplary applications include trimming silicon carbon nitride films while essentially retaining silicon oxycarbide. Applications such as these are enabled by the methods presented herein and enable new process flows. These process flows are expected to become desirable for a variety of finer linewidth structures. Methods contained herein may also be used to etch silicon-containing films faster than nitrogen-and-silicon containing films having a greater concentration of nitrogen.
Description
BACKGROUND OF THE INVENTION

Integrated circuits are made possible by processes which produce intricately patterned material layers on substrate surfaces. Producing patterned material on a substrate requires controlled methods for removal of exposed material. Chemical etching is used for a variety of purposes including transferring a pattern in photoresist into underlying layers, thinning layers or thinning lateral dimensions of features already present on the surface. Often it is desirable to have an etch process which etches one material faster than another helping e.g. a pattern transfer process proceed. Such an etch process is said to be selective to the first material. As a result of the diversity of materials, circuits and processes, etch processes have been developed with a selectivity towards a variety of materials.


A Siconi™ etch is a remote plasma assisted dry etch process which involves the simultaneous exposure of a substrate to H2, NF3 and NH3 plasma by-products. Remote plasma excitation of the hydrogen and fluorine species allows plasma-damage-free substrate processing. The Siconi™ etch is largely conformal and selective towards silicon oxide layers but does not readily etch silicon regardless of whether the silicon is amorphous, crystalline or polycrystalline. The selectivity provides advantages for applications such as shallow trench isolation (STI) and inter-layer dielectric (ILD) recess formation. The Siconi™ process produces solid by-products which grow on the surface of the substrate as substrate material is removed. The solid by-products are subsequently removed via sublimation when the temperature of the substrate is raised.


To date, remote plasma etches (such as Siconi™) have been limited to selectivity towards silicon oxide. Methods are needed to expand the range of possible selectivities for remote plasma etch processes.


BRIEF SUMMARY OF THE INVENTION

A method of etching patterned heterogeneous silicon-containing structures is described and includes a remote plasma etch with inverted selectivity compared to existing remote plasma etches. The methods may be used to conformally trim polysilicon while removing little or no silicon oxide. More generally, silicon-containing films containing less oxygen are removed more rapidly than silicon-containing films which contain more oxygen. Other exemplary applications include trimming silicon carbon nitride films while essentially retaining silicon oxycarbide. Applications such as these are enabled by the methods presented herein and enable new process flows. These process flows are expected to become desirable for a variety of finer linewidth structures. Methods contained herein may also be used to etch silicon-containing films faster than nitrogen-and-silicon containing films having a greater concentration of nitrogen.


Embodiments of the invention include methods of etching patterned substrate in a substrate processing region of a substrate processing chamber. The patterned substrate has an exposed oxygen-and-silicon-containing region and an exposed silicon-containing region which contains less oxygen than the oxygen-and-silicon-containing region. The method includes flowing a fluorine-containing precursor into a remote plasma region fluidly coupled to the substrate processing region while forming a plasma in the first plasma region to produce plasma effluents. The method further includes etching the silicon-containing region faster than the oxygen-and-silicon-containing region by flowing the plasma effluents into the substrate processing region.


Additional embodiments and features are set forth in part in the description that follows, and in part will become apparent to those skilled in the art upon examination of the specification or may be learned by the practice of the disclosed embodiments. The features and advantages of the disclosed embodiments may be realized and attained by means of the instrumentalities, combinations, and methods described in the specification.





BRIEF DESCRIPTION OF THE DRAWINGS

A further understanding of the nature and advantages of the disclosed embodiments may be realized by reference to the remaining portions of the specification and the drawings.



FIG. 1 is a flow chart of a silicon selective etch process according to disclosed embodiments.



FIGS. 2A-2B are schematics before and after a silicon selective etch process according to disclosed embodiments.



FIG. 3 is a plot indicating etch rates of silicon oxide, silicon nitride and polysilicon during a silicon selective etch according to disclosed embodiments.



FIG. 4 is a flow chart of a selective etch process according to disclosed embodiments.



FIGS. 5A-5B are schematics before and after a selective etch process according to disclosed embodiments.



FIG. 6 is a plot indicating etch rates of silicon oxycarbide and silicon carbon nitride during a selective etch according to disclosed embodiments.



FIG. 7 is a cross-sectional view of a processing chamber for performing etch processes according to disclosed embodiments.



FIG. 8 is a processing system for performing etch processes according to disclosed embodiments.





In the appended figures, similar components and/or features may have the same reference label. Further, various components of the same type may be distinguished by following the reference label by a dash and a second label that distinguishes among the similar components. If only the first reference label is used in the specification, the description is applicable to any one of the similar components having the same first reference label irrespective of the second reference label.


DETAILED DESCRIPTION OF THE INVENTION

A method of etching patterned heterogeneous silicon-containing structures is described and includes a remote plasma etch with inverted selectivity compared to existing remote plasma etches. The methods may be used to conformally trim polysilicon while removing little or no silicon oxide. More generally, silicon-containing films containing less oxygen are removed more rapidly than silicon-containing films which contain more oxygen. Other exemplary applications include trimming silicon carbon nitride films while essentially retaining silicon oxycarbide. Applications such as these are enabled by the methods presented herein and enable new process flows. These process flows are expected to become desirable for a variety of finer linewidth structures. Methods contained herein may also be used to etch silicon-containing films faster than nitrogen-and-silicon containing films having a greater concentration of nitrogen.


Siconi™ etch processes have used a hydrogen source of ammonia (NH3) and a fluorine source of nitrogen trifluoride (NF3) which together flow through a remote plasma system (RPS) and into a reaction region. The flow rates of ammonia and nitrogen trifluoride are typically chosen such that the atomic flow rate of hydrogen is roughly twice that of fluorine in order to efficiently utilize the constituents of the two process gases. The presence of hydrogen and fluorine allows the formation of solid byproducts of (NH4)2SiF6 at relatively low substrate temperatures. The solid byproducts are removed by raising the temperature of the substrate above the sublimation temperature. Siconi™ etch processes remove oxide films more rapidly than films devoid of oxygen. The inventors have discovered that the selectivity can be inverted by reducing (or eliminating) the supply of hydrogen while retaining the flow of nitrogen trifluoride.


In order to better understand and appreciate the invention, reference is now made to FIGS. 1 and 2 which are a flow chart of a oxide deselective etch process and a shallow trench isolation (STI) structure according to disclosed embodiments. Prior to the first operation, a gap is formed in a polysilicon adlayer 220-1 and an underlying silicon substrate 210. The gap is filled with silicon oxide 230 to electrically isolate devices (not shown). The silicon oxide is polished such that the surface is roughly coplanar with the top of the polysilicon and the silicon oxide is trimmed back below the polysilicon to achieve the structure shown in FIG. 2. The process of FIG. 1 begins when the substrate is transferred into a processing chamber (operation 110). Note that regions of silicon oxide 230 and polysilicon 220 are exposed on the surface of the substrate.


A flow of nitrogen trifluoride is initiated into a plasma region separate from the processing region (operation 120). Other sources of fluorine may be used to augment or replace the nitrogen trifluoride. In embodiments, the fluorine-containing precursor comprises at least one precursor selected from the group consisting of nitrogen trifluoride, diatomic fluorine, monatomic fluorine and fluorine-substituted hydrocarbons. The separate plasma region may be referred to as a remote plasma region herein and may be within a distinct module from the processing chamber or a compartment within the processing chamber. A flow of ammonia may or may not be present into the remote plasma region during this operation. When included, the hydrogen-containing precursor comprises at least one precursor selected from the group consisting of atomic hydrogen, molecular hydrogen, ammonia, a hydrocarbon and an incompletely halogen-substituted hydrocarbon. The flows of nitrogen trifluoride and optional ammonia may be selected such that the fluorine-to-hydrogen atomic flow ratio is greater than one of 2:1, 5:1 or 10:1. Products from the remote plasma (plasma effluents) are flowed into the processing region and allowed to interact with the patterned substrate surface (operation 125). The patterned layer is selectively etched (operation 130) such that the polysilicon adlayer is conformally trimmed while the silicon oxide gapfill 230 is etched more slowly in disclosed embodiments. The etch rate of the polysilicon may be greater than five or ten times the etch rate of the silicon oxide gapfill depending on the ratio of the flow of fluorine to the flow of hydrogen. The flows of the gases are then stopped (operation 135) and the substrate is removed from the processing region (operation 145). The polysilicon may be trimmed by between 1 nm and 15 nm in disclosed embodiments. Including a significant flow of oxygen into the remote plasma region (and therefore in the plasma effluent flow) is not recommended since the silicon may be oxidized thwarting the desirable etch selectivity towards silicon. The plasma region and substrate processing region are devoid or essentially devoid of oxygen during the etch process, according to embodiments of the invention.



FIG. 3 is a plot of etch quantities after a timed etch such as that used to trim the polysilicon adlayer 220 of FIG. 2. Note that a Siconi™, having about twice the atomic concentration of hydrogen as compared with fluorine, results in silicon oxide removal at a significantly greater rate than polysilicon. The selectivity inverts as the ratio of hydrogen to fluorine is reduced. Polysilicon and silicon oxide are removed at roughly the same rate when equal parts of hydrogen and fluorine are delivered to the remote plasma region. Below a ratio of 1:1 hydrogen:fluorine, the etch rate of polysilicon exceeds that of silicon oxide. Essentially no hydrogen is flowed to the remote plasma region, in embodiments, which results in an etch selectivity greater than 10:1 polysilicon:silicon oxide. The technique may also be applied to a gap in a silicon substrate without a polysilicon adlayer, in embodiments, and the oxide deselective etch would remove silicon at a greater rate than the silicon oxide gapfill.


The selective etch represented by FIGS. 1-3 was described in conjunction with a shallow-trench isolation application. A variety of other applications will benefit from this silicon-selective etch. For example, this selective etch may be used to trim the fin of a finFET structure without removing a detrimental quantity of exposed oxygen-containing material such as silicon oxide. A finFET contains a vertical protrusion of single crystalline silicon whose thickness impacts device performance. Single crystalline silicon etches at a similar rate to polysilicon when processed with the remote plasma selective etch described herein. A wide variety of alternative geometries to the device structures described herein are expected to emerge and will benefit from the oxide deselective etch.


The utility of the remote plasma etch described herein is not limited to systems including patterned silicon and silicon oxide. FIG. 4 is a flow chart of a selective etch which removes silicon carbon nitride (SiCN) faster than silicon oxy-carbide (SiOC). In embodiments the SiCN consists essentially of silicon, carbon and nitrogen. Similarly, the SiOC may consist essentially of silicon, carbon and oxygen. FIGS. 5A-5B are schematics of an exemplary application before and after the selective etch. The exemplary application involves formation of an inter-metal dielectric layer. An underlying copper layer 550 has a silicon carbon nitride (SiCN) 560-1 formed above it to prevent the diffusion of contaminants from overlying low-K film 570. A suitable SiCN film 560-1 is Blok™ and a suitable low-K film 570 is Black Diamond, each of which is available from Applied Materials, Santa Clara, Calif. The low-K film 570 is formed above the layer of SiCN 560-1 and patterned with an oxide selective etch to form the trench shown in FIG. 5A. The trench will later be filled with metal to form a conducting link between different metal layers. Before an ohmic contact can be made, however, the dielectric SiCN must first be removed.


The process of FIG. 4 begins when the patterned substrate is transferred into a processing chamber (operation 410). A flow of nitrogen trifluoride is initiated into the remote plasma region (operation 420). The remote plasma region may be essentially devoid of hydrogen or have lesser flows of hydrogen as described previously with reference to FIGS. 1-2. Hydrogen is impossible to completely eliminate from a vacuum system and “essentially devoid” of hydrogen is used to accommodate reasonable tolerances. Plasma effluents are flowed into the processing region and allowed to interact with the patterned substrate surface (operation 425). The patterned layer is selectively etched (operation 430) such that the silicon carbon nitride layer is preferentially removed relative to the silicon oxy-carbide. The selective etch continues until the portion of the SiCN is removed from the bottom of the trench to allow a subsequent layer of metal to contact the newly exposed carbon surface. The flows of the precursors are stopped (operation 435) and the substrate is removed from the processing region (operation 445). The SiCN film 560-2 following the selective etch is shown in FIG. 5B.



FIG. 6 is a plot indicating etch rates of silicon oxycarbide and silicon carbon nitride during an oxide deselective etch according to disclosed embodiments. The curves show the dependence of etch rate on the partial pressure of nitrogen trifluoride in the substrate processing region. In addition to being dependent on the hydrogen:fluorine atomic flow ratio as indicated previously, the selectivity is further dependent on the concentration of nitrogen trifluoride in the vicinity of the patterned substrate. Lower partial pressures enable an increase in the selectivity of SiCN over SiOC which is preferred in the exemplary application. Below about 50 mTorr partial pressure nitrogen trifluoride, the etch rate of both SiCN and SiOC reduce as the partial pressure is reduced. The rate of reduction is faster for the SiOC which allows the selectivity toward etching SiCN to be increased. The partial pressure of nitrogen trifluoride is below 50 mTorr, 30 mTorr or 20 mTorr in different embodiments.


The oxide deselective etch described herein etches materials which are essentially devoid of oxygen faster than oxygen-and-silicon containing films. It is noteworthy that a small amount of oxygen is often present in SiCN and polysilicon even when inclusion of oxygen is not intended. Furthermore, common measurement techniques used to determine elemental composition may over-report the presence of oxygen due to atmospheric contamination during sample preparation and measurement. Describing a material as “essentially devoid of oxygen” or “oxygen-free” accommodates these as acceptable tolerances. Even more generally, a silicon-containing film having less oxygen will etch more rapidly than a silicon-containing film having more oxygen. In embodiments, the silicon-containing film may consist essentially of silicon either in amorphous, crystalline or polycrystalline form. Similarly, the oxygen-and-silicon-containing film may consist essentially of SiO2. The oxide deselective etch may still have utility as long as both films have exposed surfaces since each will etch at a different rate. The etch rate of an exposed silicon-containing region may be greater than an etch rate of an exposed oxygen-and-silicon-containing region by a multiplicative factor greater than five in embodiments of the invention.


Oxide deselective etches have been described thus far. The methods described herein may be used to selectively etch silicon faster than silicon nitride as shown in FIG. 3. The selectivity is not as pronounced as is the case for silicon etch selectivity over silicon oxide. The difference can still be helpful in a variety of process flows. These etch processes may be referred to herein as nitride deselective etches and have the same process parameter embodiments described with reference to oxide deselective etches. Analogously, the remote plasma region and the substrate processing region may each be devoid or essentially devoid of nitrogen during these etch processes, according to embodiments of the invention. Generally speaking, silicon-containing materials may be etched selectively compared to a nitrogen-and-silicon-containing material having a greater nitrogen concentration than the silicon-containing materials. The etch rate of an exposed silicon-containing region may be greater than an etch rate of an exposed nitrogen-and-silicon-containing material by a multiplicative factor greater than 1.5 in embodiments of the invention. Silicon-containing films, such as silicon, may also be etched faster than nitrogen-oxygen-and-silicon-containing films.


Additional oxide deselective etch process parameters are disclosed in the course of describing an exemplary processing system.


Exemplary Processing System



FIG. 7 is a partial cross sectional view showing an illustrative processing chamber 700, in which, embodiments of the invention may be carried out. Generally, a hydrogen-containing precursor and a fluorine-containing precursor may be introduced through one or more apertures 751 into remote plasma region(s) 761-763 and excited by plasma power source 746.


In one embodiment, the processing chamber 700 includes a chamber body 712, a lid assembly 702, and a support assembly 710. The lid assembly 702 is disposed at an upper end of the chamber body 712, and the support assembly 710 is at least partially disposed within the chamber body 712. The processing chamber 700 and the associated hardware are preferably formed from one or more process-compatible materials (e.g. aluminum, stainless steel, etc.).


The chamber body 712 includes a slit valve opening 760 formed in a sidewall thereof to provide access to the interior of the processing chamber 700. The slit valve opening 760 is selectively opened and closed to allow access to the interior of the chamber body 712 by a wafer handling robot (not shown). In one embodiment, a wafer can be transported in and out of the processing chamber 700 through the slit valve opening 760 to an adjacent transfer chamber and/or load-lock chamber, or another chamber within a cluster tool. An exemplary cluster tool which may include processing chamber 700 is shown in FIG. 8.


In one or more embodiments, chamber body 712 includes a chamber body channel 713 for flowing a heat transfer fluid through chamber body 712. The heat transfer fluid can be a heating fluid or a coolant and is used to control the temperature of chamber body 712 during processing and substrate transfer. Heating the chamber body 712 may help to prevent unwanted condensation of the gas or byproducts on the chamber walls. Exemplary heat transfer fluids include water, ethylene glycol, or a mixture thereof. An exemplary heat transfer fluid may also include nitrogen gas. Support assembly 710 may have a support assembly channel 704 for flowing a heat transfer fluid through support assembly 710 thereby affecting the substrate temperature.


The chamber body 712 can further include a liner 733 that surrounds the support assembly 710. The liner 733 is preferably removable for servicing and cleaning. The liner 733 can be made of a metal such as aluminum, or a ceramic material. However, the liner 733 can be any process compatible material. The liner 733 can be bead blasted to increase the adhesion of any material deposited thereon, thereby preventing flaking of material which results in contamination of the processing chamber 700. In one or more embodiments, the liner 733 includes one or more apertures 735 and a pumping channel 729 formed therein that is in fluid communication with a vacuum system. The apertures 735 provide a flow path for gases into the pumping channel 729, which provides an egress for the gases within the processing chamber 700.


The vacuum system can include a vacuum pump 725 and a throttle valve 727 to regulate flow of gases through the processing chamber 700. The vacuum pump 725 is coupled to a vacuum port 731 disposed on the chamber body 712 and therefore, in fluid communication with the pumping channel 729 formed within the liner 733. The terms “gas” and “gases” are used interchangeably, unless otherwise noted, and refer to one or more reactants, catalysts, carrier, purge, cleaning, combinations thereof, as well as any other fluid introduced into the chamber body 712. The term “precursor” is used to refer to any process gas which takes part in a reaction to either remove or deposit material from a surface.


Apertures 735 allow the pumping channel 729 to be in fluid communication with a processing region 740 within the chamber body 712. The processing region 740 is defined by a lower surface of the lid assembly 702 and an upper surface of the support assembly 710, and is surrounded by the liner 733. The apertures 735 may be uniformly sized and evenly spaced about the liner 733. However, any number, position, size or shape of apertures may be used, and each of those design parameters can vary depending on the desired flow pattern of gas across the substrate receiving surface as is discussed in more detail below. In addition, the size, number and position of the apertures 735 are configured to achieve uniform flow of gases exiting the processing chamber 700. Further, the aperture size and location may be configured to provide rapid or high capacity pumping to facilitate a rapid exhaust of gas from the chamber 700. For example, the number and size of apertures 735 in close proximity to the vacuum port 731 may be smaller than the size of apertures 735 positioned farther away from the vacuum port 731.


A gas supply panel (not shown) is typically used to provide process gas(es) to the processing chamber 700 through one or more apertures 751. The particular gas or gases that are used depend upon the process or processes to be performed within the chamber 700. Illustrative gases can include, but are not limited to one or more precursors, reductants, catalysts, carriers, purge, cleaning, or any mixture or combination thereof. Typically, the one or more gases introduced to the processing chamber 700 flow into plasma volume 761 through aperture(s) 751 in top plate 750. Alternatively or in combination, processing gases may be introduced more directly through aperture(s) 752 into processing region 740. Aperture(s) 752 bypass the remote plasma excitation and are useful for processes involving gases that do not require plasma excitation or processes which do not benefit from additional excitation of the gases. Electronically operated valves and/or flow control mechanisms (not shown) may be used to control the flow of gas from the gas supply into the processing chamber 700. Depending on the process, any number of gases can be delivered to the processing chamber 700, and can be mixed either in the processing chamber 700 or before the gases are delivered to the processing chamber 700.


The lid assembly 702 can further include an electrode 745 to generate a plasma of reactive species within the lid assembly 702. In one embodiment, the electrode 745 is supported by top plate 750 and is electrically isolated therefrom by inserting electrically isolating ring(s) 747 made from aluminum oxide or any other insulating and process compatible material. In one or more embodiments, the electrode 745 is coupled to a power source 746 while the rest of lid assembly 702 is connected to ground. Accordingly, a plasma of one or more process gases can be generated in remote plasma region composed of volumes 761, 762 and/or 763 between electrode 745 and annular mounting flange 722. In embodiments, annular mounting flange comprises or supports gas delivery plate 720. For example, the plasma may be initiated and maintained between electrode 745 and one or both blocker plates of blocker assembly 730. Alternatively, the plasma can be struck and contained between the electrode 745 and gas delivery plate 720, in the absence of blocker assembly 730. In either embodiment, the plasma is well confined or contained within the lid assembly 702. Accordingly, the plasma is a “remote plasma” since no active plasma is in direct contact with the substrate disposed within the chamber body 712. As a result, plasma damage to the substrate may be avoided since the plasma is separated from the substrate surface.


A wide variety of power sources 746 are capable of activating the nitrogen-containing precursor (nitrogen trifluoride). For example, radio frequency (RF), direct current (DC), or microwave (MW) based power discharge techniques may be used. The activation may also be generated by a thermally based technique, a gas breakdown technique, a high intensity light source (e.g., UV energy), or exposure to an x-ray source. Alternatively, a remote activation source may be used, such as a remote plasma generator, to generate a plasma of reactive species which are then delivered into the chamber 700. Exemplary remote plasma generators are available from vendors such as MKS Instruments, Inc. and Advanced Energy Industries, Inc. In the exemplary processing system an RF power supply is coupled to electrode 745. A higher-power microwave power source 746 is beneficial in the event that reactive oxygen will also be produced using power source 746.


The temperatures of the process chamber body 712 and the substrate may each be controlled by flowing a heat transfer medium through chamber body channel 713 and support assembly channel 704, respectively. Support assembly channel 704 may be formed within support assembly 710 to facilitate the transfer of thermal energy. Chamber body 712 and support assembly 710 may be cooled or heated independently. For example, a heating fluid may be flown through one while a cooling fluid is flown through the other.


Other methods may be used to control the substrate temperature. The substrate may be heated by heating the support assembly 710 (or a portion thereof, such as a pedestal) with a resistive heater or by some other means. In another configuration, gas delivery plate 720 may be maintained at a temperature higher than the substrate and the substrate can be elevated in order to raise the substrate temperature. In this case the substrate is heated radiatively or by using a gas to conduct heat from gas delivery plate 720 to the substrate. The substrate may be elevated by raising support assembly 710 or by employing lift pins.


During the etch processes described herein, chamber body 712 may be maintained within an approximate temperature range of between 50° C. and 80° C., between 55° C. and 75° C. or between 60° C. and 70° C. in different embodiments. During exposure to plasma effluents and/or oxidizing agents, the substrate may be maintained below about 100° C., below about 65° C., between about 15° C. and about 50° C. or between about 22° C. and about 40° C. in different embodiments. The substrate may also be held at elevated temperatures during the etch since the oxide deselective etch does not rely as heavily if at all on a sublimation step. The substrate may be maintained above 70° C., above 100° C. or above 130° C. in disclosed embodiments.


Plasma effluents include a variety of molecules, molecular fragments and ionized species. During oxide deselective etching, plasma effluents include fluorine radicals which react readily with exposed silicon-containing material which lacks oxygen or possesses a small amount of oxygen. Plasma effluents may react with a oxygen-free silicon-containing layer to form SiF and H2O vapor products which are removed from processing region 740 by vacuum pump 725.


In embodiments, little or no hydrogen is introduced into the remote plasma region. Under such conditions, little or no solid residue is produced on the substrate surface and a sublimation step may be omitted. When a source of hydrogen is included, the substrate may be heated to sublimate solid residue etch by-products formed upon exposing the substrate to the plasma effluents. In embodiments, the gas delivery plate 720 is heatable by incorporating heating element 770 within or near gas delivery plate 720. The substrate may be heated by reducing the distance between the substrate and the heated gas delivery plate. The gas delivery plate 720 may be heated to between about 100° C. and 150° C., between about 110° C. and 140° C. or between about 120° C. and 130° C. in different embodiments. By reducing the separation between the substrate and the heated gas delivery plate, the substrate may be heated to above about 75° C., above about 90° C., above about 100° C. or between about 115° C. and about 150° C. in different embodiments. When a hydrogen source is flowed along with a fluorine source, the heat radiated from gas delivery plate 720 to the substrate should be made sufficient to dissociate or sublimate solid (NH4)2SiF6 from the oxide portions of the substrate into volatile SiF4, NH3 and HF products which may be pumped away from processing region 740.


Nitrogen trifluoride (or another fluorine-containing precursor) may be flowed into remote plasma volume 761 at rates between about 25 sccm and about 200 sccm, between about 50 sccm and about 150 sccm or between about 75 sccm and about 125 sccm in different embodiments. Ammonia (or hydrogen-containing precursors in general) may be flowed into remote plasma volume 761 at rates below or about 20 sccm, below or about 15 sccm, below or about 10 sccm, below or about 5 sccm or below or about 2 sccm in different embodiments.


Combined flow rates of hydrogen-containing and fluorine-containing precursors into the remote plasma region may account for 0.05% to about 20% by volume of the overall gas mixture; the remainder being a carrier gas. In one embodiment, a purge or carrier gas is first initiated into the remote plasma region before those of the reactive gases to stabilize the pressure within the remote plasma region.


Production of the plasma effluents occurs within volumes 761, 762 and/or 763 by applying plasma power to electrode 745 relative to the rest of lid assembly 702. Plasma power can be a variety of frequencies or a combination of multiple frequencies. In the exemplary processing system the plasma is provided by RF power delivered to electrode 745. The RF power may be between about 1 W and about 1000 W, between about 5 W and about 600 W, between about 10 W and about 300 W or between about 20 W and about 100 W in different embodiments. The RF frequency applied in the exemplary processing system may be less than about 200 kHz, less than about 150 kHz, less than about 120 kHz or between about 50 kHz and about 90 kHz in different embodiments.


Processing region 740 can be maintained at a variety of pressures during the flow of plasma effluents into processing region 740. The pressure may be maintained between about 500 mTorr and about 30 Torr, between about 1 Torr and about 10 Torr or between about 3 Torr and about 6 Torr in different embodiments. Lower pressures may also be used within processing region 740. The pressure may be maintained below or about 500 mTorr, below or about 250 mTorr, below or about 100 mTorr, below or about 50 mTorr or below or about 20 mTorr in different embodiments.


The selectivity of the etch process may be enhanced by neutralizing charged species generated in volumes 761-763 prior to flowing plasma effluents into the substrate processing region. Neutral reactive radicals (molecular fragments) are still passed into the substrate processing region and react with the substrate to perform the selective etch process. To this end, the holes in the showerhead may be narrowed to increase the neutralizing collisions as effluents migrate toward the substrate processing region. A separate showerhead may also be included in the path of the plasma effluents to suppress the flow of ions into the substrate processing region. The separate showerhead may be referred to as an ion suppressor (not shown). These neutral (uncharged) species may still include highly reactive species that are transported with less reactive carrier gas through the holes. The flow of ionized effluents into the substrate processing region may be reduced to below the flow of neutral species on a per molecular fragment basis. The flow may also be below 10% of the neutral species or may be essentially eliminated, in disclosed embodiments. Controlling the amount of ionic species passing into the substrate processing region provides increased control over the gas mixture brought into contact with the underlying wafer substrate, increasing control of the selectivity of the etch process.


A plurality of holes in the ion suppressor and/or the showerhead may be configured to control the passage of the activated gas (i.e., the ionic, radical, and/or neutral species) into the substrate processing region. For example, the aspect ratio of the holes (i.e., the hole diameter to length) and/or the geometry of the holes may be controlled so that the flow of ionically-charged species in the activated gas passing into the substrate processing region is reduced. The holes may include a tapered portion that faces the remote plasma region (volumes 761, 762 and/or 763). The taper may serve to allow a substantial number of effluents into the hole but force a large percentage of the effluents to undergo neutralizing collisions prior to entering the substrate processing region. An adjustable electrical bias may also be applied to the ion suppressor and/or showerhead as an additional means to control the flow of ionic species through the suppressor.


In one or more embodiments, the processing chamber 700 can be integrated into a variety of multi-processing platforms, including the Producer™ GT, Centura™ AP and Endura™ platforms available from Applied Materials, Inc. located in Santa Clara, Calif. Such a processing platform is capable of performing several processing operations without breaking vacuum.



FIG. 8 is a schematic top-view diagram of an illustrative multi-chamber processing system 800. The system 800 can include one or more load lock chambers 802, 804 for transferring of substrates into and out of the system 800. Typically, since the system 800 is under vacuum, the load lock chambers 802, 804 may “pump down” the substrates introduced into the system 800. A first robot 810 may transfer the substrates between the load lock chambers 802, 804, and a first set of one or more substrate processing chambers 812, 814, 816, 818 (four are shown). Each processing chamber 812, 814, 816, 818, can be outfitted to perform a number of substrate processing operations including the dry etch processes described herein in addition to cyclical layer deposition (CLD), atomic layer deposition (ALD), chemical vapor deposition (CVD), physical vapor deposition (PVD), etch, pre-clean, degas, orientation and other substrate processes.


The first robot 810 can also transfer substrates to/from one or more transfer chambers 822, 824. The transfer chambers 822, 824 can be used to maintain ultrahigh vacuum conditions while allowing substrates to be transferred within the system 800. A second robot 830 can transfer the substrates between the transfer chambers 822, 824 and a second set of one or more processing chambers 832, 834, 836, 838. Similar to processing chambers 812, 814, 816, 818, the processing chambers 832, 834, 836, 838 can be outfitted to perform a variety of substrate processing operations including the dry etch processes described herein in addition to cyclical layer deposition (CLD), atomic layer deposition (ALD), chemical vapor deposition (CVD), physical vapor deposition (PVD), etch, pre-clean, degas, and orientation, for example. Any of the substrate processing chambers 812, 814, 816, 818, 832, 834, 836, 838 may be removed from the system 800 if not necessary for a particular process to be performed by the system 800.


System controller 857 is used to control motors, valves, flow controllers, power supplies and other functions required to carry out process recipes described herein. System controller 857 may rely on feedback from optical sensors to determine and adjust the position of movable mechanical assemblies. Mechanical assemblies may include the robot, throttle valves and susceptors which are moved by motors under the control of system controller 857.


In an exemplary embodiment, system controller 857 includes a hard disk drive (memory), USB ports, a floppy disk drive and a processor. System controller 857 includes analog and digital input/output boards, interface boards and stepper motor controller boards. Various parts of multi-chamber processing system 800 which contains processing chamber 800 are controlled by system controller 857. The system controller executes system control software in the form of a computer program stored on computer-readable medium such as a hard disk, a floppy disk or a flash memory thumb drive. Other types of memory can also be used. The computer program includes sets of instructions that dictate the timing, mixture of gases, chamber pressure, chamber temperature, RF power levels, susceptor position, and other parameters of a particular process.


A process for etching, depositing or otherwise processing a film on a substrate or a process for cleaning chamber can be implemented using a computer program product that is executed by the controller. The computer program code can be written in any conventional computer readable programming language: for example, 68000 assembly language, C, C++, Pascal, Fortran or others. Suitable program code is entered into a single file, or multiple files, using a conventional text editor, and stored or embodied in a computer usable medium, such as a memory system of the computer. If the entered code text is in a high level language, the code is compiled, and the resultant compiler code is then linked with an object code of precompiled Microsoft Windows® library routines. To execute the linked, compiled object code the system user invokes the object code, causing the computer system to load the code in memory. The CPU then reads and executes the code to perform the tasks identified in the program.


The interface between a user and the controller may be via a touch-sensitive monitor and may also include a mouse and keyboard. In one embodiment two monitors are used, one mounted in the clean room wall for the operators and the other behind the wall for the service technicians. The two monitors may simultaneously display the same information, in which case only one is configured to accept input at a time. To select a particular screen or function, the operator touches a designated area on the display screen with a finger or the mouse. The touched area changes its highlighted color, or a new menu or screen is displayed, confirming the operator's selection.


As used herein “substrate” may be a support substrate with or without layers formed thereon. The support substrate may be an insulator or a semiconductor of a variety of doping concentrations and profiles and may, for example, be a semiconductor substrate of the type used in the manufacture of integrated circuits. A gas in an “excited state” describes a gas wherein at least some of the gas molecules are in vibrationally-excited, dissociated and/or ionized states. A gas may be a combination of two or more gases. “Silicon oxide” is predominantly SiO2 but may include concentrations of other elemental constituents such as nitrogen, hydrogen, carbon and the like. The terms “gap” and “trench” are used throughout with no implication that the etched geometry has a large horizontal aspect ratio. Viewed from above the surface, these structures may appear circular, oval, polygonal, rectangular, or a variety of other shapes. As used herein, a conformal etch process refers to a generally uniform removal of material on a surface in the same shape as the surface, i.e., the surface of the etched layer and the pre-etch surface are generally parallel. A person having ordinary skill in the art will recognize that the etched interface likely cannot be 100% conformal and thus the term “generally” allows for acceptable tolerances.


Having disclosed several embodiments, it will be recognized by those of skill in the art that various modifications, alternative constructions, and equivalents may be used without departing from the spirit of the disclosed embodiments. Additionally, a number of well known processes and elements have not been described in order to avoid unnecessarily obscuring the present invention. Accordingly, the above description should not be taken as limiting the scope of the invention.


Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included.


As used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a process” includes a plurality of such processes and reference to “the dielectric material” includes reference to one or more dielectric materials and equivalents thereof known to those skilled in the art, and so forth.


Also, the words “comprise,” “comprising,” “include,” “including,” and “includes” when used in this specification and in the following claims are intended to specify the presence of stated features, integers, components, or steps, but they do not preclude the presence or addition of one or more other features, integers, components, steps, acts, or groups.

Claims
  • 1. A method of etching patterned substrate in a substrate processing region of a substrate processing chamber, wherein the patterned substrate has an exposed oxygen-and-silicon-containing region and an exposed silicon-containing region which contains less oxygen than the oxygen-and-silicon-containing region, the method comprising: flowing a fluorine-containing precursor into a remote plasma region fluidly coupled to the substrate processing region while forming a plasma in the first plasma region to produce plasma effluents; andetching the silicon-containing region faster than the oxygen-and-silicon-containing region by flowing the plasma effluents into the substrate processing region, wherein the etching is performed while maintaining a partial pressure of the fluorine-containing precursor below about 100 mTorr.
  • 2. The method of claim 1 wherein an etch rate of the exposed silicon-containing region is greater than an etch rate of the exposed oxygen-and-silicon-containing region by a multiplicative factor greater than 5.
  • 3. The method of claim 1 wherein the exposed silicon-containing region is essentially devoid of oxygen.
  • 4. The method of claim 1 wherein the exposed silicon-containing region consists essentially of silicon.
  • 5. The method of claim 1 wherein the exposed oxygen-and-silicon-containing region consists essentially of SiO2.
  • 6. The method of claim 1 wherein the exposed silicon-containing region is polysilicon, the exposed oxygen-and-silicon-containing region is SiO2 and the polysilicon is trimmed by between 1 nm and 15 nm.
  • 7. The method of claim 1 wherein the exposed silicon-containing region consists essentially of silicon, carbon and nitrogen.
  • 8. The method of claim 1 wherein the exposed oxygen-and-silicon-containing region consists essentially of silicon, carbon and oxygen.
  • 9. The method of claim 1 wherein the exposed silicon-containing region is SiCN, the exposed oxygen-and-silicon-containing region is SiOC and the SiCN is removed from the base of a trench formed in the SiOC.
  • 10. The method of claim 1 wherein the fluorine-containing precursor comprises at least one precursor selected from the group consisting of nitrogen trifluoride, diatomic fluorine, monatomic fluorine and fluorine-substituted hydrocarbons.
  • 11. The method of claim 1 wherein the plasma effluents possess an atomic ratio of fluorine-to-hydrogen which is greater than 5:1.
  • 12. The method of claim 1 wherein essentially no ionized species are present in the plasma effluents within the substrate processing region to increase the etch selectivity of the silicon-containing region.
  • 13. A method of etching patterned substrate in a substrate processing region of a substrate processing chamber, wherein the patterned substrate has an exposed nitrogen-and-silicon-containing region and an exposed silicon-containing region which contains less nitrogen than the nitrogen-and-silicon-containing region, the method comprising: flowing a fluorine-containing precursor into a remote plasma region fluidly coupled to the substrate processing region while forming a plasma in the first plasma region to produce plasma effluents; andetching the silicon-containing region faster than the nitrogen-and-silicon-containing region by flowing the plasma effluents into the substrate processing region, wherein the etching is performed while maintaining a partial pressure of the fluorine-containing precursor below about 100 mTorr.
  • 14. The method of claim 13 wherein an etch rate of the exposed silicon-containing region is greater than an etch rate of the exposed nitrogen-and-silicon-containing region by a multiplicative factor greater than 1.5.
  • 15. The method of claim 13 wherein the exposed silicon-containing region is essentially devoid of nitrogen.
  • 16. The method of claim 13 wherein the exposed silicon-containing region consists essentially of silicon.
  • 17. The method of claim 13 wherein the exposed nitrogen-and-silicon-containing region consists essentially of silicon nitride.
  • 18. The method of claim 13 wherein the fluorine-containing precursor comprises at least one precursor selected from the group consisting of nitrogen trifluoride, diatomic fluorine, monatomic fluorine and fluorine-substituted hydrocarbons.
  • 19. The method of claim 13 wherein the fluorine-containing precursor and the plasma effluents are essentially devoid of hydrogen.
  • 20. The method of claim 13 wherein the plasma effluents possess an atomic ratio of fluorine-to-hydrogen which is greater than 5:1.
CROSS REFERENCES TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/088,930, filed Apr. 18, 2011, which claims the benefit of U.S. Provisional Patent Application No. 61/348,920, filed May 27, 2010, the entire disclosure of which is incorporated by reference herein for all purposes.

US Referenced Citations (1415)
Number Name Date Kind
2369620 Sullivan et al. Feb 1945 A
3451840 Hough Jun 1969 A
3537474 Rohrer Nov 1970 A
3756511 Shinroku Sep 1973 A
3937857 Brummett et al. Feb 1976 A
3969077 Hill Jul 1976 A
4006047 Brummett et al. Feb 1977 A
4209357 Gorin et al. Jun 1980 A
4214946 Forget Jul 1980 A
4232060 Mallory, Jr. Nov 1980 A
4234628 DuRose Nov 1980 A
4265943 Goldstein et al. May 1981 A
4341592 Shortes et al. Jul 1982 A
4361418 Tscheppe Nov 1982 A
4361441 Tylko Nov 1982 A
4364803 Nidola et al. Dec 1982 A
4368223 Kobayashi et al. Jan 1983 A
4374698 Sanders et al. Feb 1983 A
4397812 Mallory, Jr. Aug 1983 A
4468413 Bachmann Aug 1984 A
4565601 Kakehi et al. Jan 1986 A
4579618 Celestino et al. Apr 1986 A
4585920 Hoog et al. Apr 1986 A
4610775 Phifer Sep 1986 A
4625678 Shioya et al. Dec 1986 A
4632857 Mallory, Jr. Dec 1986 A
4656052 Satou et al. Apr 1987 A
4656076 Vetanen et al. Apr 1987 A
4668335 Mockler May 1987 A
4690746 McInerney et al. Sep 1987 A
4715937 Moslehi et al. Dec 1987 A
4749440 Blackwood et al. Jun 1988 A
4753898 Parrillo et al. Jun 1988 A
4786360 Cote et al. Nov 1988 A
4793897 Dunfield et al. Dec 1988 A
4807016 Douglas Feb 1989 A
4810520 Wu Mar 1989 A
4816638 Ukai et al. Mar 1989 A
4820377 Davis et al. Apr 1989 A
4828649 Davis et al. May 1989 A
4857140 Loewenstein Aug 1989 A
4904621 Loewenstein et al. Feb 1990 A
4913929 Moslehi et al. Apr 1990 A
4946903 Gardella et al. Aug 1990 A
4951601 Maydan et al. Aug 1990 A
4960488 Law et al. Oct 1990 A
4980018 Mu et al. Dec 1990 A
4981551 Palmour Jan 1991 A
4985372 Narita et al. Jan 1991 A
4991542 Kohmura et al. Feb 1991 A
4992136 Tachi et al. Feb 1991 A
4994404 Sheng et al. Feb 1991 A
5000113 Wang et al. Mar 1991 A
5006192 Deguchi Apr 1991 A
5013691 Lory et al. May 1991 A
5028565 Chang Jul 1991 A
5030319 Nishino et al. Jul 1991 A
5038713 Kawakami et al. Aug 1991 A
5045244 Marlett Sep 1991 A
5061838 Lane et al. Oct 1991 A
5083030 Stavov Jan 1992 A
5089441 Moslehi Feb 1992 A
5089442 Olmer Feb 1992 A
5147692 Bengston Sep 1992 A
5156881 Okano et al. Oct 1992 A
5180435 Markunas et al. Jan 1993 A
5186718 Tepman et al. Feb 1993 A
5188706 Hori et al. Feb 1993 A
5198034 deBoer et al. Mar 1993 A
5203911 Sricharoenchalkit et al. Apr 1993 A
5215787 Homma Jun 1993 A
5228501 Tepman et al. Jul 1993 A
5231690 Soma et al. Jul 1993 A
5235139 Bengston et al. Aug 1993 A
5238499 van de Ven et al. Aug 1993 A
5240497 Shacham et al. Aug 1993 A
5248371 Maher et al. Sep 1993 A
5248527 Uchida et al. Sep 1993 A
5252178 Moslehi Oct 1993 A
5266157 Kadomura Nov 1993 A
5269881 Sekiya Dec 1993 A
5270125 America et al. Dec 1993 A
5271972 Kwok et al. Dec 1993 A
5275977 Otsubo et al. Jan 1994 A
5277750 Frank Jan 1994 A
5279669 Lee Jan 1994 A
5279865 Chebi et al. Jan 1994 A
5288518 Homma Feb 1994 A
5290382 Zarowin et al. Mar 1994 A
5292370 Tsai et al. Mar 1994 A
5292682 Stevens et al. Mar 1994 A
5300463 Cathey et al. Apr 1994 A
5302233 Kim et al. Apr 1994 A
5306530 Strongin et al. Apr 1994 A
5314724 Tsukune et al. May 1994 A
5319247 Matsuura Jun 1994 A
5326427 Jerbic Jul 1994 A
5328558 Kawamura et al. Jul 1994 A
5328810 Lowrey et al. Jul 1994 A
5334552 Homma Aug 1994 A
5345999 Hosokawa Sep 1994 A
5352636 Beinglass Oct 1994 A
5356478 Chen et al. Oct 1994 A
5362526 Wang et al. Nov 1994 A
5368897 Kurihara et al. Nov 1994 A
5378316 Franke et al. Jan 1995 A
5380560 Kaja et al. Jan 1995 A
5382311 Ishikawa et al. Jan 1995 A
5384284 Doan et al. Jan 1995 A
5385763 Okano et al. Jan 1995 A
5399237 Keswick et al. Mar 1995 A
5399529 Homma Mar 1995 A
5403434 Moslehi Apr 1995 A
5413670 Langan et al. May 1995 A
5413967 Matsuda et al. May 1995 A
5415890 Kloiber et al. May 1995 A
5416048 Blalock et al. May 1995 A
5420075 Homma et al. May 1995 A
5429995 Nishiyama et al. Jul 1995 A
5439553 Grant et al. Aug 1995 A
5451259 Krogh Sep 1995 A
5464499 Moslehi Nov 1995 A
5468342 Nulty et al. Nov 1995 A
5474589 Ohga et al. Dec 1995 A
5478403 Shinagawa et al. Dec 1995 A
5478462 Walsh Dec 1995 A
5483920 Pryor Jan 1996 A
5500249 Telford et al. Mar 1996 A
5505816 Barnes et al. Apr 1996 A
5510216 Calabrese et al. Apr 1996 A
5516367 Lei et al. May 1996 A
5518962 Murao May 1996 A
5531835 Fodor et al. Jul 1996 A
5534070 Okamura et al. Jul 1996 A
5536360 Nguyen et al. Jul 1996 A
5549780 Koinuma et al. Aug 1996 A
5558717 Zhao et al. Sep 1996 A
5560779 Knowles et al. Oct 1996 A
5563105 Dobuzinsky et al. Oct 1996 A
5567243 Foster et al. Oct 1996 A
5571576 Qian et al. Nov 1996 A
5575853 Arami et al. Nov 1996 A
5578130 Hayashi et al. Nov 1996 A
5578161 Auda Nov 1996 A
5580421 Hiatt et al. Dec 1996 A
5591269 Arami et al. Jan 1997 A
5599740 Jang et al. Feb 1997 A
5614055 Fairbairn et al. Mar 1997 A
5616518 Foo et al. Apr 1997 A
5624582 Cain Apr 1997 A
5626922 Miyanaga et al. May 1997 A
5628829 Foster et al. May 1997 A
5635086 Warren, Jr. Jun 1997 A
5645645 Zhang et al. Jul 1997 A
5648125 Cane Jul 1997 A
5648175 Russell et al. Jul 1997 A
5656093 Burkhart et al. Aug 1997 A
5660957 Chou et al. Aug 1997 A
5661093 Ravi et al. Aug 1997 A
5674787 Zhao et al. Oct 1997 A
5676758 Hasgawa et al. Oct 1997 A
5679606 Wang et al. Oct 1997 A
5685946 Fathauer et al. Nov 1997 A
5688331 Aruga et al. Nov 1997 A
5695810 Dubin et al. Dec 1997 A
5712185 Tsai et al. Jan 1998 A
5716500 Bardos et al. Feb 1998 A
5716506 Maclay et al. Feb 1998 A
5719085 Moon et al. Feb 1998 A
5733816 Iyer et al. Mar 1998 A
5747373 Yu May 1998 A
5753886 Iwamura et al. May 1998 A
5755859 Brusic et al. May 1998 A
5756400 Ye et al. May 1998 A
5756402 Jimbo et al. May 1998 A
5772770 Suda et al. Jun 1998 A
5781693 Ballance et al. Jul 1998 A
5786276 Brooks et al. Jul 1998 A
5788825 Park et al. Aug 1998 A
5789300 Fulford Aug 1998 A
5800686 Littau et al. Sep 1998 A
5804259 Robles Sep 1998 A
5812403 Fong et al. Sep 1998 A
5814238 Ashby et al. Sep 1998 A
5814365 Mahawili Sep 1998 A
5820723 Benjamin et al. Oct 1998 A
5824599 Schacham-Diamand et al. Oct 1998 A
5830805 Schacham-Diamand et al. Nov 1998 A
5835334 McMillin et al. Nov 1998 A
5843538 Ehrsam et al. Dec 1998 A
5843847 Pu et al. Dec 1998 A
5844195 Fairbairn et al. Dec 1998 A
5846332 Zhao et al. Dec 1998 A
5846373 Pirkle et al. Dec 1998 A
5846375 Gilchrist et al. Dec 1998 A
5846598 Semkow et al. Dec 1998 A
5849639 Molloy et al. Dec 1998 A
5850105 Dawson et al. Dec 1998 A
5855681 Maydan et al. Jan 1999 A
5856240 Sinha et al. Jan 1999 A
5858876 Chew Jan 1999 A
5865896 Nowak Feb 1999 A
5866483 Shiau et al. Feb 1999 A
5872052 Iyer Feb 1999 A
5872058 Van Cleemput et al. Feb 1999 A
5882424 Taylor et al. Mar 1999 A
5882786 Nassau et al. Mar 1999 A
5883012 Chiou Mar 1999 A
5885404 Kim et al. Mar 1999 A
5885749 Huggins et al. Mar 1999 A
5888906 Sandhu et al. Mar 1999 A
5891349 Tobe et al. Apr 1999 A
5891513 Dubin et al. Apr 1999 A
5897751 Makowiecki Apr 1999 A
5899752 Hey et al. May 1999 A
5900163 Yi et al. May 1999 A
5904827 Reynolds May 1999 A
5907790 Kellam May 1999 A
5910340 Uchida et al. Jun 1999 A
5913147 Dubin et al. Jun 1999 A
5915190 Pirkle Jun 1999 A
5918116 Chittipeddi Jun 1999 A
5920792 Lin Jul 1999 A
5926737 Ameen et al. Jul 1999 A
5932077 Reynolds Aug 1999 A
5933757 Yoshikawa et al. Aug 1999 A
5935334 Fong et al. Aug 1999 A
5937323 Orczyk et al. Aug 1999 A
5939831 Fong et al. Aug 1999 A
5942075 Nagahata et al. Aug 1999 A
5944049 Beyer et al. Aug 1999 A
5944902 Redeker et al. Aug 1999 A
5948702 Rotondaro Sep 1999 A
5951601 Lesinski et al. Sep 1999 A
5951776 Selyutin et al. Sep 1999 A
5951896 Mahawili Sep 1999 A
5953591 Ishihara et al. Sep 1999 A
5953635 Andideh Sep 1999 A
5968610 Liu et al. Oct 1999 A
5969422 Ting et al. Oct 1999 A
5976327 Tanaka Nov 1999 A
5990000 Hong et al. Nov 1999 A
5990013 Berenguer et al. Nov 1999 A
5993916 Zhao et al. Nov 1999 A
5997962 Ogasawara et al. Dec 1999 A
6004884 Abraham Dec 1999 A
6007635 Mahawili Dec 1999 A
6007785 Liou Dec 1999 A
6010962 Liu et al. Jan 2000 A
6013191 Nasser-Faili et al. Jan 2000 A
6013584 M'Saad Jan 2000 A
6015724 Yamazaki et al. Jan 2000 A
6015747 Lopatin et al. Jan 2000 A
6017414 Koemtzopoulos et al. Jan 2000 A
6020271 Yanagida Feb 2000 A
6030666 Lam et al. Feb 2000 A
6030881 Papasouliotis et al. Feb 2000 A
6035101 Sajoto et al. Mar 2000 A
6037018 Jang et al. Mar 2000 A
6037266 Tao et al. Mar 2000 A
6039851 Iyer Mar 2000 A
6053982 Halpin et al. Apr 2000 A
6059643 Hu et al. May 2000 A
6063683 Wu et al. May 2000 A
6063712 Gilton et al. May 2000 A
6065424 Shacham-Diamand et al. May 2000 A
6072147 Koshiishi Jun 2000 A
6072227 Yau et al. Jun 2000 A
6074512 Collins et al. Jun 2000 A
6077780 Dubin Jun 2000 A
6080529 Ye et al. Jun 2000 A
6081414 Flanigan et al. Jun 2000 A
6083344 Hanawa et al. Jul 2000 A
6083844 Bui-Le et al. Jul 2000 A
6086677 Umotoy et al. Jul 2000 A
6087278 Kim et al. Jul 2000 A
6090212 Mahawili Jul 2000 A
6093457 Okumura Jul 2000 A
6093594 Yeap et al. Jul 2000 A
6099697 Hausmann Aug 2000 A
6107199 Allen et al. Aug 2000 A
6110530 Chen et al. Aug 2000 A
6110832 Morgan et al. Aug 2000 A
6110836 Cohen et al. Aug 2000 A
6110838 Loewenstein Aug 2000 A
6113771 Landau et al. Sep 2000 A
6117245 Mandrekar et al. Sep 2000 A
6120640 Shih et al. Sep 2000 A
6136163 Cheung et al. Oct 2000 A
6136685 Narwankar et al. Oct 2000 A
6136693 Chan et al. Oct 2000 A
6140234 Uzoh et al. Oct 2000 A
6144099 Lopatin et al. Nov 2000 A
6147009 Grill et al. Nov 2000 A
6149828 Vaartstra Nov 2000 A
6150628 Smith et al. Nov 2000 A
6153935 Edelstein et al. Nov 2000 A
6161576 Maher et al. Dec 2000 A
6162302 Raghavan et al. Dec 2000 A
6165912 McConnell et al. Dec 2000 A
6167834 Wang et al. Jan 2001 B1
6169021 Akram et al. Jan 2001 B1
6170428 Redeker et al. Jan 2001 B1
6171661 Zheng et al. Jan 2001 B1
6174450 Patrick et al. Jan 2001 B1
6174812 Hsiung et al. Jan 2001 B1
6176198 Kao et al. Jan 2001 B1
6176667 Fairbairn Jan 2001 B1
6177245 Ward et al. Jan 2001 B1
6179924 Zhao et al. Jan 2001 B1
6180523 Lee et al. Jan 2001 B1
6182602 Redeker et al. Feb 2001 B1
6184121 Buchwalter et al. Feb 2001 B1
6186091 Chu et al. Feb 2001 B1
6189483 Ishikawa et al. Feb 2001 B1
6190233 Hong et al. Feb 2001 B1
6194038 Rossman Feb 2001 B1
6197181 Chen Mar 2001 B1
6197364 Paunovic et al. Mar 2001 B1
6197680 Lin et al. Mar 2001 B1
6197688 Simpson Mar 2001 B1
6197705 Vassiliev Mar 2001 B1
6203863 Liu et al. Mar 2001 B1
6204200 Shieh et al. Mar 2001 B1
6210486 Mizukami et al. Apr 2001 B1
6217658 Orczyk et al. Apr 2001 B1
6220201 Nowak Apr 2001 B1
6228233 Lakshmikanthan et al. May 2001 B1
6228751 Yamazaki et al. May 2001 B1
6228758 Pellerin et al. May 2001 B1
6235643 Mui et al. May 2001 B1
6237527 Kellerman et al. May 2001 B1
6238513 Arnold et al. May 2001 B1
6238582 Williams et al. May 2001 B1
6241845 Gadgil et al. Jun 2001 B1
6242349 Nogami et al. Jun 2001 B1
6244211 Nishikawa et al. Jun 2001 B1
6245396 Nogami Jun 2001 B1
6245670 Cheung et al. Jun 2001 B1
6251236 Stevens Jun 2001 B1
6251802 Moore et al. Jun 2001 B1
6258170 Somekh et al. Jul 2001 B1
6258220 Dordi et al. Jul 2001 B1
6258223 Cheung et al. Jul 2001 B1
6258270 Hilgendorff et al. Jul 2001 B1
6261637 Oberle Jul 2001 B1
6277733 Smith Aug 2001 B1
6277752 Chen Aug 2001 B1
6277763 Kugimiya et al. Aug 2001 B1
6281072 Li et al. Aug 2001 B1
6281135 Han et al. Aug 2001 B1
6284146 Kim et al. Sep 2001 B1
6291282 Wilk et al. Sep 2001 B1
6291348 Lopatin et al. Sep 2001 B1
6303044 Koemtzopoulos Oct 2001 B1
6303418 Cha et al. Oct 2001 B1
6306772 Lin Oct 2001 B1
6308776 Sloan Oct 2001 B1
6312554 Ye Nov 2001 B1
6312995 Yu Nov 2001 B1
6319387 Krishnamoorthy et al. Nov 2001 B1
6321587 Laush Nov 2001 B1
6322716 Qiao et al. Nov 2001 B1
6323128 Sambucetti et al. Nov 2001 B1
6335288 Kwan et al. Jan 2002 B1
6340435 Bjorkman et al. Jan 2002 B1
6342733 Hu et al. Jan 2002 B1
RE37546 Mahawili Feb 2002 E
6344410 Lopatin et al. Feb 2002 B1
6348407 Gupta et al. Feb 2002 B1
6350320 Sherstinsky et al. Feb 2002 B1
6350697 Richardson Feb 2002 B1
6351013 Luning et al. Feb 2002 B1
6352081 Lu et al. Mar 2002 B1
6355573 Okumura Mar 2002 B1
6364949 Or et al. Apr 2002 B1
6364954 Umotoy et al. Apr 2002 B2
6364957 Schneider et al. Apr 2002 B1
6375748 Yudovsky et al. Apr 2002 B1
6376386 Oshima Apr 2002 B1
6379575 Yin et al. Apr 2002 B1
6383896 Kirimura et al. May 2002 B1
6383951 Li May 2002 B1
6387207 Janakiraman et al. May 2002 B1
6391753 Yu May 2002 B1
6395150 Van Cleemput et al. May 2002 B1
6403491 Liu et al. Jun 2002 B1
6415736 Hao et al. Jul 2002 B1
6416647 Dordi et al. Jul 2002 B1
6418874 Cox et al. Jul 2002 B1
6423284 Arno Jul 2002 B1
6427623 Ko Aug 2002 B2
6432819 Pavate et al. Aug 2002 B1
6432831 Dhindsa et al. Aug 2002 B2
6436193 Kasai et al. Aug 2002 B1
6436816 Lee et al. Aug 2002 B1
6440863 Tsai et al. Aug 2002 B1
6441492 Cunningham Aug 2002 B1
6446572 Brcka Sep 2002 B1
6448537 Nering Sep 2002 B1
6458718 Todd Oct 2002 B1
6461974 Ni et al. Oct 2002 B1
6462371 Weimer et al. Oct 2002 B1
6465051 Sahin et al. Oct 2002 B1
6465366 Nemani et al. Oct 2002 B1
6477980 White et al. Nov 2002 B1
6479373 Dreybrodt et al. Nov 2002 B2
6488984 Wada et al. Dec 2002 B1
6494959 Samoilov et al. Dec 2002 B1
6499425 Sandhu et al. Dec 2002 B1
6500728 Wang Dec 2002 B1
6503843 Xia et al. Jan 2003 B1
6506291 Tsai et al. Jan 2003 B2
6509623 Zhao Jan 2003 B2
6516815 Stevens et al. Feb 2003 B1
6518548 Sugaya et al. Feb 2003 B2
6527968 Wang et al. Mar 2003 B1
6528409 Lopatin et al. Mar 2003 B1
6537707 Lee Mar 2003 B1
6537733 Campana et al. Mar 2003 B2
6541397 Bencher Apr 2003 B1
6541671 Martinez et al. Apr 2003 B1
6544340 Yudovsky Apr 2003 B2
6547977 Yan et al. Apr 2003 B1
6551924 Dalton et al. Apr 2003 B1
6558564 Loewenhardt May 2003 B1
6565729 Chen et al. May 2003 B2
6569773 Gellrich et al. May 2003 B1
6572937 Hakovirta et al. Jun 2003 B2
6573030 Fairbairn et al. Jun 2003 B1
6573606 Sambucetti et al. Jun 2003 B2
6585851 Ohmi et al. Jul 2003 B1
6586163 Okabe et al. Jul 2003 B1
6596599 Guo Jul 2003 B1
6596654 Bayman et al. Jul 2003 B1
6602434 Hung et al. Aug 2003 B1
6603269 Vo et al. Aug 2003 B1
6605874 Leu et al. Aug 2003 B2
6616967 Test Sep 2003 B1
6627532 Gaillard et al. Sep 2003 B1
6635578 Xu et al. Oct 2003 B1
6638810 Bakli et al. Oct 2003 B2
6645301 Sainty et al. Nov 2003 B2
6645550 Cheung et al. Nov 2003 B1
6656831 Lee et al. Dec 2003 B1
6656837 Xu et al. Dec 2003 B2
6656848 Scanlan et al. Dec 2003 B1
6663715 Yuda et al. Dec 2003 B1
6677242 Liu et al. Jan 2004 B1
6679981 Pan et al. Jan 2004 B1
6688375 Turner Feb 2004 B1
6713356 Skotnicki et al. Mar 2004 B1
6713835 Horak et al. Mar 2004 B1
6717189 Inoue et al. Apr 2004 B2
6720213 Gambino et al. Apr 2004 B1
6740585 Yoon et al. May 2004 B2
6740977 Ahn et al. May 2004 B2
6743473 Parkhe et al. Jun 2004 B1
6743732 Lin et al. Jun 2004 B1
6756235 Liu et al. Jun 2004 B1
6759261 Shimokohbe et al. Jul 2004 B2
6762127 Boiteux et al. Jul 2004 B2
6762435 Towle Jul 2004 B2
6764958 Nemani et al. Jul 2004 B1
6765273 Chau et al. Jul 2004 B1
6767834 Chung et al. Jul 2004 B2
6770166 Fisher Aug 2004 B1
6772827 Keller et al. Aug 2004 B2
6792889 Nakano et al. Sep 2004 B2
6794290 Papasouliotis et al. Sep 2004 B1
6794311 Huang et al. Sep 2004 B2
6796314 Graff et al. Sep 2004 B1
6797189 Hung et al. Sep 2004 B2
6800336 Fornsel et al. Oct 2004 B1
6800830 Mahawili Oct 2004 B2
6802944 Ahmad et al. Oct 2004 B2
6808564 Dietze Oct 2004 B2
6808748 Kapoor et al. Oct 2004 B2
6821571 Huang Nov 2004 B2
6823589 White et al. Nov 2004 B2
6828241 Kholodenko et al. Dec 2004 B2
6830624 Janakiraman et al. Dec 2004 B2
6835995 Li Dec 2004 B2
6846745 Papasouliotis et al. Jan 2005 B1
6849854 Sainty Feb 2005 B2
6852550 Tuttle et al. Feb 2005 B2
6858153 Bjorkman et al. Feb 2005 B2
6861097 Goosey et al. Mar 2005 B1
6861332 Park et al. Mar 2005 B2
6869880 Krishnaraj et al. Mar 2005 B2
6875280 Ikeda et al. Apr 2005 B2
6878206 Tzu et al. Apr 2005 B2
6879981 Rothschild et al. Apr 2005 B2
6886491 Kim et al. May 2005 B2
6892669 Xu et al. May 2005 B2
6893967 Wright et al. May 2005 B1
6897532 Schwarz et al. May 2005 B1
6900596 Yang et al. May 2005 B2
6903511 Chistyakov Jun 2005 B2
6908862 Li et al. Jun 2005 B2
6911112 An Jun 2005 B2
6911401 Khandan et al. Jun 2005 B2
6921556 Shimizu et al. Jul 2005 B2
6924191 Liu et al. Aug 2005 B2
6930047 Yamazaki Aug 2005 B2
6935269 Lee et al. Aug 2005 B2
6942753 Choi et al. Sep 2005 B2
6946033 Tsuel et al. Sep 2005 B2
6951821 Hamelin et al. Oct 2005 B2
6958175 Sakamoto et al. Oct 2005 B2
6958286 Chen et al. Oct 2005 B2
6995073 Liou Feb 2006 B2
7017269 White et al. Mar 2006 B2
7018941 Cui et al. Mar 2006 B2
7030034 Fucsko et al. Apr 2006 B2
7049200 Arghavani et al. May 2006 B2
7052553 Shih et al. May 2006 B1
7071532 Geffken et al. Jul 2006 B2
7084070 Lee et al. Aug 2006 B1
7115525 Abatchev et al. Oct 2006 B2
7122949 Strikovski Oct 2006 B2
7145725 Hasel et al. Dec 2006 B2
7148155 Tarafdar et al. Dec 2006 B1
7166233 Johnson et al. Jan 2007 B2
7183214 Nam et al. Feb 2007 B2
7196342 Ershov et al. Mar 2007 B2
7226805 Hallin et al. Jun 2007 B2
7235137 Kitayama et al. Jun 2007 B2
7244474 Hanawa et al. Jul 2007 B2
7252011 Traverso Aug 2007 B2
7252716 Kim et al. Aug 2007 B2
7253123 Arghavani et al. Aug 2007 B2
7256370 Guiver Aug 2007 B2
7288482 Panda et al. Oct 2007 B2
7291360 Hanawa et al. Nov 2007 B2
7316761 Doan et al. Jan 2008 B2
7329608 Babayan et al. Feb 2008 B2
7341633 Lubomirsky et al. Mar 2008 B2
7344912 Okoroanyanwu Mar 2008 B1
7358192 Merry et al. Apr 2008 B2
7361865 Maki et al. Apr 2008 B2
7364956 Saito Apr 2008 B2
7365016 Ouellet et al. Apr 2008 B2
7396480 Kao et al. Jul 2008 B2
7416989 Liu et al. Aug 2008 B1
7465358 Weidman et al. Dec 2008 B2
7465953 Koh et al. Dec 2008 B1
7468319 Lee Dec 2008 B2
7484473 Keller et al. Feb 2009 B2
7488688 Chung et al. Feb 2009 B2
7494545 Lam et al. Feb 2009 B2
7500445 Zhao et al. Mar 2009 B2
7553756 Hayashi et al. Jun 2009 B2
7575007 Tang et al. Aug 2009 B2
7581511 Mardian et al. Sep 2009 B2
7604708 Wood et al. Oct 2009 B2
7611980 Wells Nov 2009 B2
7628897 Mungekar et al. Dec 2009 B2
7682518 Chandrachood et al. Mar 2010 B2
7695590 Hanawa et al. Apr 2010 B2
7708859 Huang et al. May 2010 B2
7722925 White et al. May 2010 B2
7723221 Hayashi May 2010 B2
7749326 Kim et al. Jul 2010 B2
7785672 Choi et al. Aug 2010 B2
7790634 Munro et al. Sep 2010 B2
7806077 Lee et al. Oct 2010 B2
7806078 Yoshida Oct 2010 B2
7807578 Bencher et al. Oct 2010 B2
7825038 Ingle et al. Nov 2010 B2
7837828 Ikeda et al. Nov 2010 B2
7845309 Condrashoff et al. Dec 2010 B2
7867926 Satoh et al. Jan 2011 B2
7915139 Lang et al. Mar 2011 B1
7932181 Singh et al. Apr 2011 B2
7939422 Ingle et al. May 2011 B2
7968441 Xu Jun 2011 B2
7976631 Burrows Jul 2011 B2
7981806 Jung Jul 2011 B2
7989365 Park et al. Aug 2011 B2
8008166 Sanchez et al. Aug 2011 B2
8048811 Feustel et al. Nov 2011 B2
8058179 Draeger et al. Nov 2011 B1
8071482 Kawada Dec 2011 B2
8074599 Choi et al. Dec 2011 B2
8076198 Lee et al. Dec 2011 B2
8083853 Choi et al. Dec 2011 B2
8114245 Ohmi et al. Feb 2012 B2
8119530 Hori et al. Feb 2012 B2
8133349 Panagopoulos Mar 2012 B1
8183134 Wu May 2012 B2
8187486 Liu et al. May 2012 B1
8211808 Sapre et al. Jul 2012 B2
8272346 Bettencourt et al. Sep 2012 B2
8295089 Jeong et al. Oct 2012 B2
8298627 Minami et al. Oct 2012 B2
8309440 Sanchez et al. Nov 2012 B2
8312839 Baek Nov 2012 B2
8313610 Dhindsa Nov 2012 B2
8328939 Choi et al. Dec 2012 B2
8336188 Monteen Dec 2012 B2
8357435 Lubomirsky Jan 2013 B2
8368308 Banna et al. Feb 2013 B2
8390980 Sansoni et al. Mar 2013 B2
8427067 Espiau et al. Apr 2013 B2
8435902 Tang et al. May 2013 B2
8440523 Guillorn et al. May 2013 B1
8475674 Thadani et al. Jul 2013 B2
8480850 Tyler et al. Jul 2013 B2
8491805 Kushibiki et al. Jul 2013 B2
8501629 Tang et al. Aug 2013 B2
8506713 Takagi Aug 2013 B2
8512509 Bera et al. Aug 2013 B2
8528889 Nakano et al. Sep 2013 B2
8540844 Hudson et al. Sep 2013 B2
8551891 Liang Oct 2013 B2
8573152 De La Llera Nov 2013 B2
8622021 Taylor et al. Jan 2014 B2
8623471 Tyler et al. Jan 2014 B2
8652298 Dhindsa et al. Feb 2014 B2
8679982 Wang et al. Mar 2014 B2
8679983 Wang et al. Mar 2014 B2
8702902 Blom et al. Apr 2014 B2
8741778 Yang et al. Jun 2014 B2
8747680 Deshpande Jun 2014 B1
8765574 Zhang et al. Jul 2014 B2
8771536 Zhang et al. Jul 2014 B2
8771539 Zhang et al. Jul 2014 B2
8772888 Jung et al. Jul 2014 B2
8778079 Begarney et al. Jul 2014 B2
8801952 Wang et al. Aug 2014 B1
8808563 Wang et al. Aug 2014 B2
8846163 Kao et al. Sep 2014 B2
8869742 Dhindsa Oct 2014 B2
8871651 Choi et al. Oct 2014 B1
8888087 Okabe et al. Nov 2014 B2
8895449 Zhu et al. Nov 2014 B1
8900364 Wright Dec 2014 B2
8921234 Liu et al. Dec 2014 B2
8927390 Sapre et al. Jan 2015 B2
8951429 Liu et al. Feb 2015 B1
8956980 Chen et al. Feb 2015 B1
8969212 Ren et al. Mar 2015 B2
8980005 Carlson et al. Mar 2015 B2
8980758 Ling et al. Mar 2015 B1
8980763 Wang et al. Mar 2015 B2
8992723 Sorensen et al. Mar 2015 B2
8999656 Jirstrom et al. Apr 2015 B2
8999839 Su et al. Apr 2015 B2
8999856 Zhang et al. Apr 2015 B2
9012302 Sapre et al. Apr 2015 B2
9017481 Pettinger et al. Apr 2015 B1
9023732 Wang et al. May 2015 B2
9023734 Chen et al. May 2015 B2
9034770 Park et al. May 2015 B2
9040422 Wang et al. May 2015 B2
9064815 Zhang et al. Jun 2015 B2
9064816 Kim et al. Jun 2015 B2
9072158 Ikeda et al. Jun 2015 B2
9093371 Wang et al. Jul 2015 B2
9093390 Wang et al. Jul 2015 B2
9111877 Chen et al. Aug 2015 B2
9111907 Kamineni Aug 2015 B2
9114438 Hoinkis et al. Aug 2015 B2
9117855 Cho et al. Aug 2015 B2
9132436 Liang et al. Sep 2015 B2
9136273 Purayath et al. Sep 2015 B1
9144147 Yang et al. Sep 2015 B2
9153442 Wang et al. Oct 2015 B2
9159606 Purayath et al. Oct 2015 B1
9165786 Purayath et al. Oct 2015 B1
9184055 Wang et al. Nov 2015 B2
9190293 Wang et al. Nov 2015 B2
9190302 Ni Nov 2015 B2
9209012 Chen et al. Dec 2015 B2
9236265 Korolik et al. Jan 2016 B2
9236266 Zhang et al. Jan 2016 B2
9245762 Zhang et al. Jan 2016 B2
9263278 Purayath et al. Feb 2016 B2
9269590 Luere et al. Feb 2016 B2
9275834 Park et al. Mar 2016 B1
9287095 Nguyen et al. Mar 2016 B2
9287134 Wang et al. Mar 2016 B2
9293568 Ko Mar 2016 B2
9299537 Kobayashi et al. Mar 2016 B2
9299538 Kobayashi et al. Mar 2016 B2
9299575 Park et al. Mar 2016 B2
9299582 Ingle et al. Mar 2016 B2
9299583 Wang et al. Mar 2016 B1
9309598 Wang et al. Apr 2016 B2
9324576 Zhang et al. Apr 2016 B2
9343272 Pandit et al. May 2016 B1
9343327 Zhange et al. May 2016 B2
9349605 Xu et al. May 2016 B1
9355856 Wang et al. May 2016 B2
9355862 Pandit et al. May 2016 B2
9355863 Chen et al. May 2016 B2
9355922 Park et al. May 2016 B2
9362130 Ingle et al. Jun 2016 B2
9368364 Park et al. Jun 2016 B2
9373517 Yang et al. Jun 2016 B2
9373522 Wang et al. Jun 2016 B1
9378969 Hsu et al. Jun 2016 B2
9378978 Purayath et al. Jun 2016 B2
9384997 Ren et al. Jul 2016 B2
9385028 Nemani et al. Jul 2016 B2
9390937 Chen et al. Jul 2016 B2
9396989 Purayath et al. Jul 2016 B2
9406523 Chen et al. Aug 2016 B2
9412608 Wang et al. Aug 2016 B2
9418858 Wang et al. Aug 2016 B2
9425058 Kim et al. Aug 2016 B2
9437451 Chen et al. Sep 2016 B2
9449845 Liu et al. Sep 2016 B2
9449846 Liu et al. Sep 2016 B2
9449850 Wang et al. Sep 2016 B2
9472412 Zhang et al. Oct 2016 B2
9472417 Ingle et al. Oct 2016 B2
9478432 Chen et al. Oct 2016 B2
9478434 Wang et al. Oct 2016 B2
9493879 Hoinkis et al. Nov 2016 B2
9496167 Purayath et al. Nov 2016 B2
9499898 Nguyen et al. Nov 2016 B2
9502258 Xue et al. Nov 2016 B2
9520303 Wang et al. Dec 2016 B2
9564296 Kobayashi et al. Feb 2017 B2
9576809 Korolik et al. Feb 2017 B2
9607856 Wang et al. Mar 2017 B2
9613822 Chen et al. Apr 2017 B2
20010006093 Tabuchi Jul 2001 A1
20010008803 Takamatsu et al. Jul 2001 A1
20010015261 Kobayashi et al. Aug 2001 A1
20010028093 Yamazaki et al. Oct 2001 A1
20010028922 Sandhu Oct 2001 A1
20010030366 Nakano et al. Oct 2001 A1
20010034106 Moise et al. Oct 2001 A1
20010034121 Fu et al. Oct 2001 A1
20010035124 Okayama et al. Nov 2001 A1
20010036706 Kitamura Nov 2001 A1
20010037856 Park Nov 2001 A1
20010037941 Thompson Nov 2001 A1
20010039921 Rolfson et al. Nov 2001 A1
20010042512 Xu et al. Nov 2001 A1
20010053585 Kikuchi et al. Dec 2001 A1
20010053610 Athavale Dec 2001 A1
20020000202 Yuda et al. Jan 2002 A1
20020001778 Latchford et al. Jan 2002 A1
20020011210 Satoh et al. Jan 2002 A1
20020011214 Kamarehi et al. Jan 2002 A1
20020016080 Khan et al. Feb 2002 A1
20020016085 Huang et al. Feb 2002 A1
20020023899 Khater et al. Feb 2002 A1
20020028582 Nallan et al. Mar 2002 A1
20020028585 Chung et al. Mar 2002 A1
20020029747 Powell et al. Mar 2002 A1
20020033233 Savas Mar 2002 A1
20020036143 Segawa et al. Mar 2002 A1
20020040764 Kwan et al. Apr 2002 A1
20020040766 Takahashi Apr 2002 A1
20020043690 Doyle et al. Apr 2002 A1
20020045966 Lee et al. Apr 2002 A1
20020054962 Huang May 2002 A1
20020069820 Yudovsky Jun 2002 A1
20020070414 Drescher et al. Jun 2002 A1
20020074573 Takeuchi et al. Jun 2002 A1
20020090781 Skotnicki et al. Jul 2002 A1
20020090835 Chakravarti et al. Jul 2002 A1
20020094378 O-Donnell Jul 2002 A1
20020094591 Sill et al. Jul 2002 A1
20020096493 Hattori Jul 2002 A1
20020098681 Hu et al. Jul 2002 A1
20020106845 Chao et al. Aug 2002 A1
20020112819 Kamarehi et al. Aug 2002 A1
20020124867 Kim et al. Sep 2002 A1
20020129769 Kim et al. Sep 2002 A1
20020129902 Babayan et al. Sep 2002 A1
20020144657 Chiang et al. Oct 2002 A1
20020153808 Skotnicki et al. Oct 2002 A1
20020164885 Lill et al. Nov 2002 A1
20020177322 Li et al. Nov 2002 A1
20020182878 Hirose et al. Dec 2002 A1
20020187280 Johnson et al. Dec 2002 A1
20020187655 Tan et al. Dec 2002 A1
20030003757 Naltan et al. Jan 2003 A1
20030007910 Lazarovich et al. Jan 2003 A1
20030010645 Ting et al. Jan 2003 A1
20030019428 Ku et al. Jan 2003 A1
20030019580 Strang Jan 2003 A1
20030026060 Hiramatsu et al. Feb 2003 A1
20030029566 Roth Feb 2003 A1
20030029567 Dhindsa et al. Feb 2003 A1
20030029715 Yu et al. Feb 2003 A1
20030032284 Enomoto et al. Feb 2003 A1
20030038127 Liu et al. Feb 2003 A1
20030038305 Wasshuber Feb 2003 A1
20030054608 Tseng et al. Mar 2003 A1
20030071035 Brailove Apr 2003 A1
20030072639 White et al. Apr 2003 A1
20030075808 Inoue et al. Apr 2003 A1
20030077909 Jiwari Apr 2003 A1
20030079686 Chen et al. May 2003 A1
20030087531 Kang et al. May 2003 A1
20030091938 Fairbairn et al. May 2003 A1
20030094134 Minami et al. May 2003 A1
20030098125 An May 2003 A1
20030109143 Hsieh et al. Jun 2003 A1
20030116087 Nguyen et al. Jun 2003 A1
20030116439 Seo et al. Jun 2003 A1
20030121608 Chen et al. Jul 2003 A1
20030121609 Ohmi et al. Jul 2003 A1
20030124465 Lee et al. Jul 2003 A1
20030124842 Hytros et al. Jul 2003 A1
20030127740 Hsu et al. Jul 2003 A1
20030129106 Sorensen et al. Jul 2003 A1
20030129827 Lee et al. Jul 2003 A1
20030132319 Hytros et al. Jul 2003 A1
20030140844 Maa et al. Jul 2003 A1
20030143328 Chen et al. Jul 2003 A1
20030148035 Lingampalli Aug 2003 A1
20030152691 Baude Aug 2003 A1
20030159307 Sago et al. Aug 2003 A1
20030168439 Kanno et al. Sep 2003 A1
20030170945 Igeta et al. Sep 2003 A1
20030173333 Wang et al. Sep 2003 A1
20030173347 Guiver Sep 2003 A1
20030173675 Watanabe Sep 2003 A1
20030181040 Ivanov et al. Sep 2003 A1
20030183244 Rossman Oct 2003 A1
20030190426 Padhi et al. Oct 2003 A1
20030199170 Li Oct 2003 A1
20030200929 Otsuki Oct 2003 A1
20030205329 Gujer et al. Nov 2003 A1
20030215963 AmRhein et al. Nov 2003 A1
20030216044 Lin et al. Nov 2003 A1
20030221780 Lei et al. Dec 2003 A1
20030224217 Byun et al. Dec 2003 A1
20030224617 Baek et al. Dec 2003 A1
20040005726 Huang Jan 2004 A1
20040018304 Chung et al. Jan 2004 A1
20040020801 Solling Feb 2004 A1
20040026371 Nguyen et al. Feb 2004 A1
20040033678 Arghavani et al. Feb 2004 A1
20040033684 Li Feb 2004 A1
20040050328 Kumagai et al. Mar 2004 A1
20040058293 Nguyen et al. Mar 2004 A1
20040069225 Fairbairn et al. Apr 2004 A1
20040070346 Choi Apr 2004 A1
20040072446 Liu et al. Apr 2004 A1
20040076529 Gnauck et al. Apr 2004 A1
20040083967 Yuda et al. May 2004 A1
20040087139 Yeh et al. May 2004 A1
20040092063 Okumura May 2004 A1
20040099378 Kim et al. May 2004 A1
20040101667 O'Loughlin et al. May 2004 A1
20040107908 Collins et al. Jun 2004 A1
20040108067 Fischione et al. Jun 2004 A1
20040108068 Senzaki et al. Jun 2004 A1
20040115876 Goundar et al. Jun 2004 A1
20040129671 Ji et al. Jul 2004 A1
20040137161 Segawa et al. Jul 2004 A1
20040144490 Zhao et al. Jul 2004 A1
20040147126 Yamashita et al. Jul 2004 A1
20040149394 Doan et al. Aug 2004 A1
20040152342 Li Aug 2004 A1
20040154535 Chen et al. Aug 2004 A1
20040157444 Chiu Aug 2004 A1
20040161921 Ryu Aug 2004 A1
20040175913 Johnson et al. Sep 2004 A1
20040175929 Schmitt et al. Sep 2004 A1
20040182315 Laflamme et al. Sep 2004 A1
20040192032 Ohmori et al. Sep 2004 A1
20040194799 Kim et al. Oct 2004 A1
20040200499 Harvey et al. Oct 2004 A1
20040211357 Gadgil et al. Oct 2004 A1
20040219737 Quon Nov 2004 A1
20040219789 Wood et al. Nov 2004 A1
20040231706 Bhatnagar et al. Nov 2004 A1
20040263827 Xu Dec 2004 A1
20050001276 Gao et al. Jan 2005 A1
20050003676 Ho et al. Jan 2005 A1
20050009340 Saijo et al. Jan 2005 A1
20050009358 Choi et al. Jan 2005 A1
20050026430 Kim et al. Feb 2005 A1
20050026431 Kazumi Feb 2005 A1
20050035455 Hu et al. Feb 2005 A1
20050051094 Schaepkens et al. Mar 2005 A1
20050073051 Yamamoto et al. Apr 2005 A1
20050079706 Kumar et al. Apr 2005 A1
20050090078 Ishihara Apr 2005 A1
20050090120 Hasegawa et al. Apr 2005 A1
20050098111 Shimizu et al. May 2005 A1
20050105991 Hofmeister et al. May 2005 A1
20050112876 Wu May 2005 A1
20050112901 Ji et al. May 2005 A1
20050164479 Perng et al. Jul 2005 A1
20050167394 Liu et al. Aug 2005 A1
20050176258 Hirose et al. Aug 2005 A1
20050181588 Kim Aug 2005 A1
20050183666 Tsuji et al. Aug 2005 A1
20050196967 Savas et al. Sep 2005 A1
20050199489 Stevens et al. Sep 2005 A1
20050205110 Kao et al. Sep 2005 A1
20050205862 Koemtzopoulos et al. Sep 2005 A1
20050208215 Eguchi et al. Sep 2005 A1
20050214477 Hanawa et al. Sep 2005 A1
20050218507 Kao et al. Oct 2005 A1
20050219786 Brown et al. Oct 2005 A1
20050221552 Kao et al. Oct 2005 A1
20050230350 Kao et al. Oct 2005 A1
20050236694 Wu et al. Oct 2005 A1
20050239282 Chen et al. Oct 2005 A1
20050251990 Choi et al. Nov 2005 A1
20050266622 Arghavani et al. Dec 2005 A1
20050266650 Ahn et al. Dec 2005 A1
20050266691 Gu et al. Dec 2005 A1
20050269030 Kent et al. Dec 2005 A1
20050274324 Takahashi et al. Dec 2005 A1
20050279454 Snijders Dec 2005 A1
20050287755 Bachmann Dec 2005 A1
20050287771 Seamons et al. Dec 2005 A1
20060000802 Kumar et al. Jan 2006 A1
20060000805 Todorow et al. Jan 2006 A1
20060005856 Sun et al. Jan 2006 A1
20060005930 Ikeda et al. Jan 2006 A1
20060006057 Laermer Jan 2006 A1
20060011298 Lim et al. Jan 2006 A1
20060011299 Condrashoff et al. Jan 2006 A1
20060016783 Wu et al. Jan 2006 A1
20060019456 Bu et al. Jan 2006 A1
20060019486 Yu et al. Jan 2006 A1
20060021574 Armour et al. Feb 2006 A1
20060024954 Wu et al. Feb 2006 A1
20060024956 Zhijian et al. Feb 2006 A1
20060033678 Lubomirsky et al. Feb 2006 A1
20060040055 Nguyen et al. Feb 2006 A1
20060043066 Kamp Mar 2006 A1
20060046412 Nguyen et al. Mar 2006 A1
20060046419 Sandhu et al. Mar 2006 A1
20060046470 Becknell Mar 2006 A1
20060051966 Or et al. Mar 2006 A1
20060051968 Joshi et al. Mar 2006 A1
20060054184 Mozetic et al. Mar 2006 A1
20060060942 Minixhofer et al. Mar 2006 A1
20060087644 McMillin et al. Apr 2006 A1
20060093756 Rajagopalan et al. May 2006 A1
20060097397 Russell et al. May 2006 A1
20060102076 Smith et al. May 2006 A1
20060102587 Kimura May 2006 A1
20060118178 Desbiolles et al. Jun 2006 A1
20060121724 Yue et al. Jun 2006 A1
20060124242 Kanarik et al. Jun 2006 A1
20060130971 Chang et al. Jun 2006 A1
20060157449 Takahashi et al. Jul 2006 A1
20060162661 Jung et al. Jul 2006 A1
20060166107 Chen et al. Jul 2006 A1
20060166515 Karim et al. Jul 2006 A1
20060169327 Shajii et al. Aug 2006 A1
20060178008 Yeh et al. Aug 2006 A1
20060185592 Matsuura Aug 2006 A1
20060191479 Mizukami et al. Aug 2006 A1
20060191637 Zajac et al. Aug 2006 A1
20060207504 Hasebe et al. Sep 2006 A1
20060207595 Ohmi et al. Sep 2006 A1
20060210723 Ishizaka Sep 2006 A1
20060216878 Lee Sep 2006 A1
20060219360 Iwasaki Oct 2006 A1
20060222481 Foree Oct 2006 A1
20060226121 Aoi Oct 2006 A1
20060228889 Edelberg et al. Oct 2006 A1
20060240661 Annapragada et al. Oct 2006 A1
20060244107 Sugihara Nov 2006 A1
20060246217 Weidman et al. Nov 2006 A1
20060251800 Weidman et al. Nov 2006 A1
20060251801 Weidman et al. Nov 2006 A1
20060252252 Zhu et al. Nov 2006 A1
20060252265 Jin et al. Nov 2006 A1
20060254716 Mosden et al. Nov 2006 A1
20060260750 Rueger Nov 2006 A1
20060261490 Su et al. Nov 2006 A1
20060264043 Stewart et al. Nov 2006 A1
20060266288 Choi Nov 2006 A1
20060292846 Pinto et al. Dec 2006 A1
20070025907 Rezeq Feb 2007 A1
20070048977 Lee et al. Mar 2007 A1
20070056925 Liu et al. Mar 2007 A1
20070062453 Ishikawa Mar 2007 A1
20070071888 Shanmugasundram et al. Mar 2007 A1
20070072408 Enomoto et al. Mar 2007 A1
20070090325 Hwang et al. Apr 2007 A1
20070099428 Shamiryan et al. May 2007 A1
20070099431 Li May 2007 A1
20070099438 Ye et al. May 2007 A1
20070107750 Sawin et al. May 2007 A1
20070108404 Stewart et al. May 2007 A1
20070111519 Lubomirsky et al. May 2007 A1
20070117396 Wu et al. May 2007 A1
20070119370 Ma et al. May 2007 A1
20070119371 Ma et al. May 2007 A1
20070123051 Arghavani et al. May 2007 A1
20070131274 Stollwerck et al. Jun 2007 A1
20070145023 Holber et al. Jun 2007 A1
20070154838 Lee Jul 2007 A1
20070163440 Kim et al. Jul 2007 A1
20070175861 Hwang et al. Aug 2007 A1
20070181057 Lam et al. Aug 2007 A1
20070193515 Jeon et al. Aug 2007 A1
20070197028 Byun et al. Aug 2007 A1
20070207275 Nowak et al. Sep 2007 A1
20070212288 Holst Sep 2007 A1
20070227554 Satoh et al. Oct 2007 A1
20070231109 Pak et al. Oct 2007 A1
20070235134 Iimuro Oct 2007 A1
20070238199 Yamashita Oct 2007 A1
20070238321 Futase et al. Oct 2007 A1
20070243685 Jiang et al. Oct 2007 A1
20070243714 Shin et al. Oct 2007 A1
20070254169 Kamins et al. Nov 2007 A1
20070259467 Tweet et al. Nov 2007 A1
20070264820 Liu Nov 2007 A1
20070266946 Choi Nov 2007 A1
20070277734 Lubomirsky et al. Dec 2007 A1
20070281106 Lubomirsky et al. Dec 2007 A1
20070287292 Li et al. Dec 2007 A1
20070296967 Gupta et al. Dec 2007 A1
20080017104 Matyushkin et al. Jan 2008 A1
20080020570 Naik Jan 2008 A1
20080044990 Lee Feb 2008 A1
20080063810 Park et al. Mar 2008 A1
20080075668 Goldstein Mar 2008 A1
20080081483 Wu Apr 2008 A1
20080085604 Hoshino et al. Apr 2008 A1
20080099147 Myo et al. May 2008 A1
20080099431 Kumar et al. May 2008 A1
20080099876 Seto May 2008 A1
20080102570 Fisher et al. May 2008 A1
20080102640 Hassan et al. May 2008 A1
20080104782 Hughes May 2008 A1
20080115726 Ingle et al. May 2008 A1
20080121970 Aritome May 2008 A1
20080124937 Xu et al. May 2008 A1
20080142831 Su Jun 2008 A1
20080153306 Cho et al. Jun 2008 A1
20080156771 Jeon et al. Jul 2008 A1
20080157225 Datta et al. Jul 2008 A1
20080160210 Yang et al. Jul 2008 A1
20080171407 Nakabayashi et al. Jul 2008 A1
20080173906 Zhu Jul 2008 A1
20080176412 Komeda Jul 2008 A1
20080182381 Kiyotoshi Jul 2008 A1
20080182383 Lee et al. Jul 2008 A1
20080202892 Smith et al. Aug 2008 A1
20080230519 Takahashi Sep 2008 A1
20080233709 Conti et al. Sep 2008 A1
20080236751 Aramaki et al. Oct 2008 A1
20080254635 Benzel et al. Oct 2008 A1
20080261404 Kozuka et al. Oct 2008 A1
20080264337 Sano et al. Oct 2008 A1
20080268645 Kao et al. Oct 2008 A1
20080292798 Huh et al. Nov 2008 A1
20080293248 Park et al. Nov 2008 A1
20090001480 Cheng Jan 2009 A1
20090004849 Eun Jan 2009 A1
20090014127 Shah et al. Jan 2009 A1
20090014323 Yendler et al. Jan 2009 A1
20090017227 Fu et al. Jan 2009 A1
20090045167 Maruyama Feb 2009 A1
20090072401 Arnold et al. Mar 2009 A1
20090081878 Dhindsa Mar 2009 A1
20090084317 Wu et al. Apr 2009 A1
20090087960 Cho et al. Apr 2009 A1
20090087979 Raghuram Apr 2009 A1
20090095621 Kao et al. Apr 2009 A1
20090098706 Kim et al. Apr 2009 A1
20090104738 Ring et al. Apr 2009 A1
20090104782 Lu et al. Apr 2009 A1
20090111280 Kao et al. Apr 2009 A1
20090120464 Rasheed et al. May 2009 A1
20090170221 Jacques et al. Jul 2009 A1
20090170331 Cheng et al. Jul 2009 A1
20090179300 Arai Jul 2009 A1
20090189246 Wu et al. Jul 2009 A1
20090194810 Kiyotoshi et al. Aug 2009 A1
20090197418 Sago Aug 2009 A1
20090202721 Nogami et al. Aug 2009 A1
20090255902 Satoh et al. Oct 2009 A1
20090258162 Furuta et al. Oct 2009 A1
20090269934 Kao et al. Oct 2009 A1
20090274590 Willwerth et al. Nov 2009 A1
20090275146 Takano et al. Nov 2009 A1
20090275205 Kiehlbauch et al. Nov 2009 A1
20090275206 Katz et al. Nov 2009 A1
20090277587 Lubomirsky et al. Nov 2009 A1
20090277874 Rui et al. Nov 2009 A1
20090280650 Lubomirsky et al. Nov 2009 A1
20090286400 Heo et al. Nov 2009 A1
20090294898 Feustel et al. Dec 2009 A1
20090317978 Higashi Dec 2009 A1
20090320756 Tanaka Dec 2009 A1
20100003824 Kadkhodayan et al. Jan 2010 A1
20100022030 Ditizio Jan 2010 A1
20100047080 Bruce Feb 2010 A1
20100048027 Cheng et al. Feb 2010 A1
20100055408 Lee et al. Mar 2010 A1
20100055917 Kim Mar 2010 A1
20100059889 Gosset et al. Mar 2010 A1
20100062603 Ganguly et al. Mar 2010 A1
20100075503 Bencher Mar 2010 A1
20100081285 Chen et al. Apr 2010 A1
20100093151 Arghavani et al. Apr 2010 A1
20100093168 Naik Apr 2010 A1
20100096367 Jeon et al. Apr 2010 A1
20100099236 Kwon et al. Apr 2010 A1
20100099263 Kao et al. Apr 2010 A1
20100101727 Ji Apr 2010 A1
20100105209 Winniczek et al. Apr 2010 A1
20100116788 Singh et al. May 2010 A1
20100130001 Noguchi May 2010 A1
20100144140 Chandrashekar et al. Jun 2010 A1
20100147219 Hsieh et al. Jun 2010 A1
20100164422 Shu et al. Jul 2010 A1
20100173499 Tao et al. Jul 2010 A1
20100178748 Subramanian Jul 2010 A1
20100178755 Lee et al. Jul 2010 A1
20100180819 Hatanaka et al. Jul 2010 A1
20100183825 Becker et al. Jul 2010 A1
20100187534 Nishi et al. Jul 2010 A1
20100187588 Kim et al. Jul 2010 A1
20100187694 Yu et al. Jul 2010 A1
20100190352 Jaiswal Jul 2010 A1
20100197143 Nishimura Aug 2010 A1
20100203739 Becker et al. Aug 2010 A1
20100207205 Grebs et al. Aug 2010 A1
20100240205 Son Sep 2010 A1
20100258913 Lue Oct 2010 A1
20100288369 Chang et al. Nov 2010 A1
20100294199 Tran et al. Nov 2010 A1
20100330814 Yokota et al. Dec 2010 A1
20110005607 Desbiolles et al. Jan 2011 A1
20110008950 Xu Jan 2011 A1
20110011338 Chuc et al. Jan 2011 A1
20110034035 Liang et al. Feb 2011 A1
20110039407 Nishizuka Feb 2011 A1
20110045676 Park Feb 2011 A1
20110053380 Sapre et al. Mar 2011 A1
20110058303 Migita Mar 2011 A1
20110061810 Ganguly et al. Mar 2011 A1
20110061812 Ganguly et al. Mar 2011 A1
20110065276 Ganguly et al. Mar 2011 A1
20110081782 Liang et al. Apr 2011 A1
20110100489 Orito et al. May 2011 A1
20110111596 Kanakasabapathy May 2011 A1
20110114601 Lubomirsky et al. May 2011 A1
20110115378 Lubomirsky et al. May 2011 A1
20110124144 Schlemm et al. May 2011 A1
20110127156 Foad et al. Jun 2011 A1
20110140229 Rachmady et al. Jun 2011 A1
20110143542 Feurprier et al. Jun 2011 A1
20110151674 Tang et al. Jun 2011 A1
20110151677 Wang et al. Jun 2011 A1
20110151678 Ashtiani et al. Jun 2011 A1
20110155181 Inatomi Jun 2011 A1
20110159690 Chandrashekar et al. Jun 2011 A1
20110165057 Honda et al. Jul 2011 A1
20110165771 Ring et al. Jul 2011 A1
20110180847 Ikeda et al. Jul 2011 A1
20110195575 Wang Aug 2011 A1
20110217851 Liang et al. Sep 2011 A1
20110226734 Sumiya et al. Sep 2011 A1
20110227028 Sekar et al. Sep 2011 A1
20110230008 Lakshmanan et al. Sep 2011 A1
20110230052 Tang et al. Sep 2011 A1
20110232737 Ruletzki et al. Sep 2011 A1
20110266252 Thadani et al. Nov 2011 A1
20110266682 Edelstein et al. Nov 2011 A1
20110287633 Lee et al. Nov 2011 A1
20110294300 Zhang et al. Dec 2011 A1
20110298061 Siddiqui et al. Dec 2011 A1
20120003782 Byun et al. Jan 2012 A1
20120009796 Cui et al. Jan 2012 A1
20120025289 Liang et al. Feb 2012 A1
20120031559 Dhindsa et al. Feb 2012 A1
20120034786 Dhindsa et al. Feb 2012 A1
20120035766 Shajii et al. Feb 2012 A1
20120052683 Kim et al. Mar 2012 A1
20120068242 Shin et al. Mar 2012 A1
20120091108 Lin et al. Apr 2012 A1
20120103518 Kakimoto May 2012 A1
20120104564 Won et al. May 2012 A1
20120129354 Luong May 2012 A1
20120135576 Lee et al. May 2012 A1
20120148369 Michalski et al. Jun 2012 A1
20120149200 Culp et al. Jun 2012 A1
20120161405 Mohn et al. Jun 2012 A1
20120164839 Nishimura Jun 2012 A1
20120180954 Yang et al. Jul 2012 A1
20120181599 Lung Jul 2012 A1
20120182808 Lue et al. Jul 2012 A1
20120196447 Yang et al. Aug 2012 A1
20120202408 Shajii et al. Aug 2012 A1
20120208361 Ha Aug 2012 A1
20120211462 Zhang et al. Aug 2012 A1
20120223048 Paranjpe et al. Sep 2012 A1
20120223418 Stowers et al. Sep 2012 A1
20120225557 Serry et al. Sep 2012 A1
20120228642 Aube et al. Sep 2012 A1
20120238102 Zhang et al. Sep 2012 A1
20120238103 Zhang et al. Sep 2012 A1
20120241411 Darling et al. Sep 2012 A1
20120247390 Sawada et al. Oct 2012 A1
20120247670 Dobashi et al. Oct 2012 A1
20120247671 Sugawara Oct 2012 A1
20120258600 Godet et al. Oct 2012 A1
20120267346 Kao et al. Oct 2012 A1
20120282779 Arnold et al. Nov 2012 A1
20120285619 Matyushkin et al. Nov 2012 A1
20120285621 Tan Nov 2012 A1
20120292664 Kanike Nov 2012 A1
20120309204 Kang et al. Dec 2012 A1
20130001899 Hwang et al. Jan 2013 A1
20130005103 Liu et al. Jan 2013 A1
20130005140 Jeng et al. Jan 2013 A1
20130012032 Liu et al. Jan 2013 A1
20130032574 Liu et al. Feb 2013 A1
20130034666 Liang et al. Feb 2013 A1
20130034968 Zhang et al. Feb 2013 A1
20130045605 Wang et al. Feb 2013 A1
20130052827 Wang et al. Feb 2013 A1
20130052833 Ranjan et al. Feb 2013 A1
20130059440 Wang et al. Mar 2013 A1
20130062675 Thomas Mar 2013 A1
20130065398 Ohsawa et al. Mar 2013 A1
20130082197 Yang et al. Apr 2013 A1
20130084654 Gaylord et al. Apr 2013 A1
20130089988 Wang et al. Apr 2013 A1
20130098868 Nishimura et al. Apr 2013 A1
20130105948 Kewley May 2013 A1
20130119016 Kagoshima May 2013 A1
20130119457 Lue et al. May 2013 A1
20130119483 Alptekin et al. May 2013 A1
20130130507 Wang et al. May 2013 A1
20130150303 Kungl et al. Jun 2013 A1
20130161726 Kim et al. Jun 2013 A1
20130171810 Sun et al. Jul 2013 A1
20130175654 Muckenhirn et al. Jul 2013 A1
20130187220 Surthi Jul 2013 A1
20130193108 Zheng Aug 2013 A1
20130217243 Underwood et al. Aug 2013 A1
20130224960 Payyapilly et al. Aug 2013 A1
20130260533 Sapre et al. Oct 2013 A1
20130260564 Sapre et al. Oct 2013 A1
20130279066 Lubomirsky et al. Oct 2013 A1
20130284369 Kobayashi et al. Oct 2013 A1
20130284370 Kobayashi et al. Oct 2013 A1
20130284373 Sun et al. Oct 2013 A1
20130284374 Lubomirsky et al. Oct 2013 A1
20130286530 Lin et al. Oct 2013 A1
20130295297 Chou et al. Nov 2013 A1
20130298942 Ren et al. Nov 2013 A1
20130302980 Chandrashekar et al. Nov 2013 A1
20130337655 Lee et al. Dec 2013 A1
20130343829 Benedetti et al. Dec 2013 A1
20140004707 Thedjoisworo et al. Jan 2014 A1
20140004708 Thedjoisworo Jan 2014 A1
20140008880 Miura et al. Jan 2014 A1
20140020708 Kim et al. Jan 2014 A1
20140021673 Chen et al. Jan 2014 A1
20140026813 Wang et al. Jan 2014 A1
20140057447 Yang et al. Feb 2014 A1
20140062285 Chen Mar 2014 A1
20140065842 Anthis et al. Mar 2014 A1
20140080308 Chen et al. Mar 2014 A1
20140080309 Park Mar 2014 A1
20140080310 Chen et al. Mar 2014 A1
20140083362 Lubomirsky et al. Mar 2014 A1
20140087488 Nam et al. Mar 2014 A1
20140097270 Liang et al. Apr 2014 A1
20140099794 Ingle et al. Apr 2014 A1
20140124364 Yoo et al. May 2014 A1
20140134847 Seya May 2014 A1
20140141621 Ren et al. May 2014 A1
20140147126 Linnartz et al. May 2014 A1
20140152312 Snow et al. Jun 2014 A1
20140154668 Chou et al. Jun 2014 A1
20140166617 Chen Jun 2014 A1
20140166618 Tadigadapa et al. Jun 2014 A1
20140186772 Pohlers et al. Jul 2014 A1
20140190410 Kim Jul 2014 A1
20140191388 Chen Jul 2014 A1
20140199851 Nemani et al. Jul 2014 A1
20140209245 Yamamoto et al. Jul 2014 A1
20140225504 Kaneko et al. Aug 2014 A1
20140227881 Lubomirsky et al. Aug 2014 A1
20140234466 Gao et al. Aug 2014 A1
20140248773 Tsai et al. Sep 2014 A1
20140248780 Ingle et al. Sep 2014 A1
20140256131 Wang et al. Sep 2014 A1
20140256145 Abdallah et al. Sep 2014 A1
20140262031 Belostotskiy et al. Sep 2014 A1
20140262038 Wang et al. Sep 2014 A1
20140263172 Xie et al. Sep 2014 A1
20140263272 Duan et al. Sep 2014 A1
20140264533 Simsek-Ege Sep 2014 A1
20140271097 Wang et al. Sep 2014 A1
20140273373 Makala et al. Sep 2014 A1
20140273406 Wang et al. Sep 2014 A1
20140273451 Wang et al. Sep 2014 A1
20140273462 Simsek-Ege et al. Sep 2014 A1
20140273489 Wang et al. Sep 2014 A1
20140273491 Zhang et al. Sep 2014 A1
20140273492 Anthis et al. Sep 2014 A1
20140273496 Kao Sep 2014 A1
20140288528 Py et al. Sep 2014 A1
20140302678 Paterson et al. Oct 2014 A1
20140302680 Singh Oct 2014 A1
20140308758 Nemani et al. Oct 2014 A1
20140308816 Wang et al. Oct 2014 A1
20140311581 Belostotskiy et al. Oct 2014 A1
20140342532 Zhu Nov 2014 A1
20140342569 Zhu et al. Nov 2014 A1
20140349477 Chandrashekar et al. Nov 2014 A1
20140357083 Ling et al. Dec 2014 A1
20150011096 Chandrasekharan et al. Jan 2015 A1
20150014152 Hoinkis et al. Jan 2015 A1
20150031211 Sapre et al. Jan 2015 A1
20150037980 Rha Feb 2015 A1
20150060265 Cho et al. Mar 2015 A1
20150076110 Wu et al. Mar 2015 A1
20150076586 Rabkin et al. Mar 2015 A1
20150079797 Chen et al. Mar 2015 A1
20150118858 Takaba Apr 2015 A1
20150126035 Diao et al. May 2015 A1
20150126039 Korolik et al. May 2015 A1
20150126040 Korolik et al. May 2015 A1
20150129541 Wang et al. May 2015 A1
20150129545 Ingle et al. May 2015 A1
20150129546 Ingle et al. May 2015 A1
20150132953 Nowling May 2015 A1
20150132968 Ren et al. May 2015 A1
20150152072 Cantat et al. Jun 2015 A1
20150155177 Zhang et al. Jun 2015 A1
20150170879 Nguyen et al. Jun 2015 A1
20150170920 Purayath et al. Jun 2015 A1
20150170924 Nguyen et al. Jun 2015 A1
20150170926 Michalak Jun 2015 A1
20150170935 Wang et al. Jun 2015 A1
20150170943 Nguyen et al. Jun 2015 A1
20150171008 Luo Jun 2015 A1
20150179464 Wang et al. Jun 2015 A1
20150187625 Busche et al. Jul 2015 A1
20150206764 Wang et al. Jul 2015 A1
20150214066 Luere et al. Jul 2015 A1
20150214067 Zhang et al. Jul 2015 A1
20150214092 Purayath et al. Jul 2015 A1
20150214337 Ko et al. Jul 2015 A1
20150221541 Nemani et al. Aug 2015 A1
20150235809 Ito et al. Aug 2015 A1
20150235863 Chen Aug 2015 A1
20150235865 Wang et al. Aug 2015 A1
20150235867 Nishizuka Aug 2015 A1
20150247231 Nguyen et al. Sep 2015 A1
20150249018 Park et al. Sep 2015 A1
20150270140 Gupta et al. Sep 2015 A1
20150275361 Lubomirsky et al. Oct 2015 A1
20150275375 Kim et al. Oct 2015 A1
20150294980 Lee et al. Oct 2015 A1
20150332930 Wang et al. Nov 2015 A1
20150340225 Kim et al. Nov 2015 A1
20150345029 Wang et al. Dec 2015 A1
20150357201 Chen et al. Dec 2015 A1
20150357205 Wang et al. Dec 2015 A1
20150371861 Li et al. Dec 2015 A1
20150371864 Hsu et al. Dec 2015 A1
20150371865 Chen et al. Dec 2015 A1
20150371866 Chen et al. Dec 2015 A1
20150380431 Kanamori et al. Dec 2015 A1
20160005572 Liang et al. Jan 2016 A1
20160005833 Collins et al. Jan 2016 A1
20160027654 Kim et al. Jan 2016 A1
20160027673 Wang et al. Jan 2016 A1
20160035586 Purayath et al. Feb 2016 A1
20160035614 Purayath et al. Feb 2016 A1
20160042968 Purayath et al. Feb 2016 A1
20160056167 Wang et al. Feb 2016 A1
20160064233 Wang et al. Mar 2016 A1
20160079072 Wang et al. Mar 2016 A1
20160086807 Park et al. Mar 2016 A1
20160086808 Zhang et al. Mar 2016 A1
20160086815 Pandit et al. Mar 2016 A1
20160086816 Wang et al. Mar 2016 A1
20160093505 Chen et al. Mar 2016 A1
20160093506 Chen et al. Mar 2016 A1
20160104606 Park et al. Apr 2016 A1
20160118268 Ingle et al. Apr 2016 A1
20160148821 Singh et al. May 2016 A1
20160163512 Lubomirsky Jun 2016 A1
20160163513 Lubomirsky Jun 2016 A1
20160181112 Xue et al. Jun 2016 A1
20160189933 Kobayashi et al. Jun 2016 A1
20160204009 Nguyen et al. Jul 2016 A1
20160218018 Liu et al. Jul 2016 A1
20160222522 Wang et al. Aug 2016 A1
20160225651 Tran et al. Aug 2016 A1
20160225652 Tran et al. Aug 2016 A1
20160237570 Tan et al. Aug 2016 A1
20160240402 Park et al. Aug 2016 A1
20160260588 Park et al. Sep 2016 A1
20160260616 Li et al. Sep 2016 A1
20160260619 Zhang et al. Sep 2016 A1
20160284556 Ingle et al. Sep 2016 A1
20160300694 Yang et al. Oct 2016 A1
20170040175 Xu et al. Feb 2017 A1
20170040190 Benjaminson et al. Feb 2017 A1
20170040191 Benjaminson et al. Feb 2017 A1
20170040207 Purayath Feb 2017 A1
20170062184 Tran et al. Mar 2017 A1
Foreign Referenced Citations (37)
Number Date Country
1013-15889 Dec 2008 CN
100514564 Jul 2009 CN
1675160 Jun 2006 EP
56-100422 Aug 1981 JP
S59-126778 Jul 1984 JP
H01-200627 Aug 1989 JP
H02-114525 Apr 1990 JP
H07-153739 Jun 1995 JP
H8-31755 Feb 1996 JP
H08-264510 Oct 1996 JP
2003-174020 Jun 2003 JP
2005-050908 Feb 2005 JP
2010-180458 Aug 2010 JP
4763293 Aug 2011 JP
2012-19164 Jan 2012 JP
2013-243418 Dec 2013 JP
10-2000-008278 Feb 2000 KR
2003-0023964 Mar 2003 KR
100441297 Jul 2004 KR
10-2005-0007143 Jan 2005 KR
10-2005-0042701 May 2005 KR
2005-0049903 May 2005 KR
100712727 Apr 2007 KR
2007-0079870 Aug 2007 KR
10-2008-0063988 Jul 2008 KR
10-2009-0128913 Dec 2009 KR
10-2011-0086540 Jul 2011 KR
10-2011-0126675 Nov 2011 KR
10-2012-0082640 Jul 2012 KR
2011-27983 Aug 2011 TW
2012-07919 Feb 2012 TW
2012-33842 Aug 2012 TW
2008-112673 Sep 2008 WO
2009-084194 Jul 2009 WO
2010-010706 Jan 2010 WO
2012-118987 Sep 2012 WO
2012-125656 Sep 2012 WO
Non-Patent Literature Citations (11)
Entry
H. Xiao, Introduction to Semiconductor Manufacturing Technology, published by Prentice Hall, 2001, ISBN 0-13-022404-9, pp. 354-356.
International Search Report and Written Opinion of PCT/US2011/035598 mailed Jan. 18, 2012, all pages.
International Preliminary Report on Patentability of PCT/US2011/035598 mailed Dec. 6, 2012, all pages.
Office Action mailed Mar. 4, 2016 in Taiwan Patent Application No. 100116201 all pages.
Office Action mailed Dec. 31, 2014 in Chinese Patent Application No. 201180026160.8 all pages.
Office Action mailed Jun. 30, 2015 in Chinese Patent Application No. 201180026160.8 all pages.
Office Action mailed Oct. 10, 2015 in Chinese Patent Application No. 201180026160.8 all pages.
Office Action mailed Jan. 29, 2016 in Chinese Patent Application No. 201180026160.8 all pages.
Instrument Manual: Vacuum Gauge Model MM200, Rev D. TELEVAC (website: www.televac.com), A Division of the Fredericks Company, Huntingdonvalley, PA, US. 2008. pp. 162.
International Search Report and Written Opinion of PCT/US2016/045551 mailed Nov. 17, 2016, all pages.
International Search Report and Written Opinion of PCT/US2016/045543 mailed Nov. 17, 2016, all pages.
Related Publications (1)
Number Date Country
20160240389 A1 Aug 2016 US
Provisional Applications (1)
Number Date Country
61348920 May 2010 US
Continuations (1)
Number Date Country
Parent 13088930 Apr 2011 US
Child 15137754 US